LeMaitre Vascular Inc
Buy, Hold or Sell?

Let's analyse Lemaitre together

Penke I guess you are interested in LeMaitre Vascular Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of LeMaitre Vascular Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about LeMaitre Vascular Inc

I send you an email if I find something interesting about LeMaitre Vascular Inc.

Quick analysis of Lemaitre (30 sec.)

What can you expect buying and holding a share of Lemaitre? (30 sec.)

How much money do you get?

$0.55

When do you have the money?

1 year

How often do you get paid?

100.0%

What is your share worth?

Current worth

$13.26

Expected worth in 1 year

$14.52

How sure are you?

97.5%

+ What do you gain per year?

Total Gains per Share

$1.81

Return On Investment

2.9%

For what price can you sell your share?

Current Price per Share

$62.99

Expected price per share

$58.38 - $70.89

How sure are you?

50%

1. Valuation of Lemaitre (5 min.)

Live pricePrice per Share (EOD)

$62.99

Book Value per Share

$13.26

Intrinsic Value Per Share

$-1.13 - $16.83

Total Value Per Share

$12.13 - $30.09

My calculation of the intrinsic value of Lemaitre is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($0.21) 3Y: ($0.30) TTM: ($0.33)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($-0.01) TTM: ($0.07)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$0.67	$1.29	$0.62 - $1.37
2	$1.11	$2.68	$0.40 - $1.52
3	$1.35	$4.17	$0.19 - $1.67
4	$1.40	$5.76	$-0.02 - $1.82
5	$1.29	$7.43	$-0.23 - $1.97
6	$1.03	$9.17	$-0.44 - $2.12
7	$0.65	$10.99	$-0.65 - $2.27
8	$0.15	$12.88	$-0.86 - $2.42
9	$-0.45	$14.83	$-1.07 - $2.57
10	$-1.13	$16.83	$-1.28 - $2.72

2. Growth of Lemaitre (5 min.)

Is Lemaitre growing?

	Current year	Previous year	Grow	Grow %
How rich?	$297.9m	$261.3m	$24.8m	8.7%

How much money is Lemaitre making?

	Current year	Previous year	Grow	Grow %
Making money	$7.5m	$5.1m	$2.3m	31.5%
Net Profit Margin	15.5%	12.8%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Lemaitre (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

Richest
#75 / 169

Most Revenue
#95 / 169

Most Profit
#70 / 169

Most Efficient
#36 / 169

What can you expect buying and holding a share of Lemaitre? (5 min.)

Welcome investor! Lemaitre's management wants to use your money to grow the business. In return you get a share of Lemaitre.

What can you expect buying and holding a share of Lemaitre?

First you should know what it really means to hold a share of Lemaitre. And how you can make/lose money.

Speculation

The Price per Share of Lemaitre is $62.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Lemaitre.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lemaitre, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $13.26. Based on the TTM, the Book Value Change Per Share is $0.31 per quarter. Based on the YOY, the Book Value Change Per Share is $0.16 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.14 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Lemaitre.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	0.38	0.6%	0.34	0.5%	0.23	0.4%	0.26	0.4%	0.20	0.3%
Usd Book Value Change Per Share	0.43	0.7%	0.31	0.5%	0.16	0.2%	0.37	0.6%	0.27	0.4%
Usd Dividend Per Share	0.14	0.2%	0.14	0.2%	0.12	0.2%	0.11	0.2%	0.08	0.1%
Usd Total Gains Per Share	0.56	0.9%	0.45	0.7%	0.28	0.4%	0.48	0.8%	0.35	0.5%
Usd Price Per Share	56.76	-	57.50	-	47.18	-	44.26	-	32.46	-
Price to Earnings Ratio	37.65	-	43.17	-	53.22	-	43.46	-	34.07	-
Price-to-Total Gains Ratio	100.68	-	130.63	-	199.66	-	134.58	-	90.64	-
Price to Book Ratio	4.28	-	4.51	-	4.03	-	4.74	-	4.80	-
Price-to-Total Gains Ratio	100.68	-	130.63	-	199.66	-	134.58	-	90.64	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	62.99
Number of shares	15

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.14	0.11
Usd Book Value Change Per Share	0.31	0.37
Usd Total Gains Per Share	0.45	0.48
Gains per Quarter (15 shares)	6.80	7.20
Gains per Year (15 shares)	27.18	28.82

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	8	19	17	7	22	19
2	17	38	44	13	45	48
3	25	57	71	20	67	77
4	33	75	98	26	89	106
5	42	94	125	33	112	135
6	50	113	152	39	134	164
7	58	132	179	46	156	193
8	67	151	206	52	178	222
9	75	170	233	59	201	251
10	83	189	260	65	223	280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	39.0	1.0	0.0	97.5%	69.0	10.0	0.0	87.3%
Book Value Change Per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	37.0	3.0	0.0	92.5%	57.0	17.0	5.0	72.2%
Dividend per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	40.0	0.0	0.0	100.0%	52.0	0.0	27.0	65.8%
Total Gains per Share	4.0	0.0	0.0	100.0%	12.0	0.0	0.0	100.0%	20.0	0.0	0.0	100.0%	39.0	1.0	0.0	97.5%	64.0	10.0	5.0	81.0%

Fundamentals of Lemaitre

About LeMaitre Vascular Inc

https://www.lemaitre.com
Medical Instruments & Supplies
614
63 Second Avenue, Burlington, MA, United States, 01803
Google Maps Bing Maps

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 13:30:03.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of LeMaitre Vascular Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Lemaitre earns for each $1 of revenue.

Above 10% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
A Net Profit Margin of 17.3% means that $0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of LeMaitre Vascular Inc:

The MRQ is 17.3%. The company is making a huge profit. +2
The TTM is 15.5%. The company is making a huge profit. +2

Trends

Current period		Compared to		+/-
MRQ	17.3%	TTM	15.5%	+1.8%
TTM	15.5%	YOY	12.8%	+2.7%
TTM	15.5%	5Y	15.4%	+0.1%
5Y	15.4%	10Y	14.3%	+1.1%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	17.3%	6.2%	+11.1%
TTM	15.5%	6.2%	+9.3%
YOY	12.8%	8.0%	+4.8%
5Y	15.4%	7.3%	+8.1%
10Y	14.3%	6.8%	+7.5%

Measures how much net profit Lemaitre earns for each $1 of revenue.

Revenue is the amount of profit Lemaitre generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Lemaitre earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be used to compare companies within the Medical Instruments & Supplies industry.

You typically want a high profit margin. This means that for each $1 in sales, Lemaitre makes more profit. This shows the investor how efficiently Lemaitre is operating in general and compared to other companies in the same industry. Lemaitre operates in the Medical Instruments & Supplies industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Lemaitre. If profit margins remain low (compared to the Medical Instruments & Supplies industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Lemaitre is 0.17. This means that Lemaitre earned $0.17 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Medical Instruments & Supplies industry is 6.2%.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Lemaitre with other companies in the same industry (Medical Instruments & Supplies).
Net profit margin should rise over the years.
Can be influenced when Lemaitre sells assets (profit will increase while costs remain the same).
It won’t show what part of Lemaitre is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Lemaitre

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Lemaitre = 8,465
Total revenue MRQ Lemaitre = 48,883
$8,465 / $48,883 = 0.17 or 17.3%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Lemaitre is using its assets to generate profit.

Above 5% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
2.4% Return on Assets means that Lemaitre generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of LeMaitre Vascular Inc:

The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
The TTM is 2.3%. Using its assets, the company is less efficient in making profit.

Trends

Current period		Compared to		+/-
MRQ	2.4%	TTM	2.3%	+0.2%
TTM	2.3%	YOY	1.7%	+0.6%
TTM	2.3%	5Y	2.3%	+0.0%
5Y	2.3%	10Y	2.5%	-0.3%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	2.4%	1.3%	+1.1%
TTM	2.3%	1.4%	+0.9%
YOY	1.7%	1.9%	-0.2%
5Y	2.3%	2.2%	+0.1%
10Y	2.5%	2.0%	+0.5%

Shows how efficient Lemaitre is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Lemaitre is using its resources to generate profit. If the return on assets (2.4%) from Lemaitre are higher than the Medical Instruments & Supplies mean (1.3%) that means Lemaitre is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Lemaitre is 2.4%. This means the company generated $0.02 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Medical Instruments & Supplies industry is 1.3%.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Lemaitre

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Lemaitre = 8,465
Total assets MRQ (balance sheet) from Lemaitre = 346,778
8,465 / 346,778 = 0.02 or 2.4%

ROA is an important ratio as it will tell you how effectively Lemaitre is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Lemaitre is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
2.8% Return on Equity means Lemaitre generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of LeMaitre Vascular Inc:

The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1

Trends

Current period		Compared to		+/-
MRQ	2.8%	TTM	2.6%	+0.2%
TTM	2.6%	YOY	2.0%	+0.7%
TTM	2.6%	5Y	2.9%	-0.2%
5Y	2.9%	10Y	3.0%	-0.2%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	2.8%	2.6%	+0.2%
TTM	2.6%	2.8%	-0.2%
YOY	2.0%	3.7%	-1.7%
5Y	2.9%	3.9%	-1.0%
10Y	3.0%	3.9%	-0.9%

Shows how efficient Lemaitre is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Medical Instruments & Supplies industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Lemaitre is 2.8%. This means Lemaitre generated $0.03 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Medical Instruments & Supplies industry is 2.6%.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if Lemaitre existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Lemaitre

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Lemaitre = 8,465
Shareholders equity (balance sheet) MRQ Lemaitre = 297,900
8,465 / 297,900 = 0.03 or 2.8%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of LeMaitre Vascular Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Lemaitre is operating .

Measures how much profit Lemaitre makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
An Operating Margin of 20.8% means the company generated $0.21 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of LeMaitre Vascular Inc:

The MRQ is 20.8%. The company is operating efficient. +1
The TTM is 18.9%. The company is operating efficient. +1

Trends

Current period		Compared to		+/-
MRQ	20.8%	TTM	18.9%	+1.8%
TTM	18.9%	YOY	13.0%	+5.9%
TTM	18.9%	5Y	15.4%	+3.6%
5Y	15.4%	10Y	13.2%	+2.1%

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	20.8%	7.9%	+12.9%
TTM	18.9%	7.6%	+11.3%
YOY	13.0%	10.9%	+2.1%
5Y	15.4%	10.1%	+5.3%
10Y	13.2%	10.5%	+2.7%

Measures how efficient Lemaitre is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Lemaitre is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Lemaitre is 20.8%. This means that Lemaitre earned $0.21 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Medical Instruments & Supplies industry is 7.9%.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Lemaitre

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Lemaitre = 10,154
Total revenue MRQ Lemaitre = 48,883
$10,154 / $48,883 = 0.21 or 20.8%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Lemaitre is keeping operating costs low.

Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of LeMaitre Vascular Inc:

The MRQ is 0.792. The company is efficient in keeping operating costs low. +1
The TTM is 0.808. The company is less efficient in keeping operating costs low.

Trends

Current period		Compared to		+/-
MRQ	0.792	TTM	0.808	-0.016
TTM	0.808	YOY	0.815	-0.007
TTM	0.808	5Y	0.799	+0.009
5Y	0.799	10Y	0.817	-0.018

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.792	1.153	-0.361
TTM	0.808	1.168	-0.360
YOY	0.815	1.105	-0.290
5Y	0.799	1.097	-0.298
10Y	0.817	1.056	-0.239

Measures how efficient Lemaitre is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Lemaitre is 79.2%. This means that Lemaitre earned $0.79 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Medical Instruments & Supplies industry is 1.15.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Lemaitre

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(17,106 +21,623) \ 48,883 = 0.79

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of LeMaitre Vascular Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Lemaitre is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A Current Ratio of 6.32 means the company has $6.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of LeMaitre Vascular Inc:

The MRQ is 6.321. The company is very able to pay all its short-term debts. +2
The TTM is 6.560. The company is very able to pay all its short-term debts. +2

Trends

Current period		Compared to		+/-
MRQ	6.321	TTM	6.560	-0.239
TTM	6.560	YOY	6.751	-0.192
TTM	6.560	5Y	5.382	+1.178
5Y	5.382	10Y	5.562	-0.180

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	6.321	2.302	+4.019
TTM	6.560	2.333	+4.227
YOY	6.751	2.588	+4.163
5Y	5.382	2.627	+2.755
10Y	5.562	2.623	+2.939

Measures if Lemaitre is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Lemaitre if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Lemaitre is 6.32. This means Lemaitre has $6.32 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 2.30.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Lemaitre

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
188,851 \ 29,879) = 6.32

The current ratio measures if Lemaitre is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Lemaitre is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Lemaitre does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Lemaitre is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Lemaitre is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
A Quick Ratio of 7.06 means the company can pay off $7.06 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of LeMaitre Vascular Inc:

The MRQ is 7.060. The company is very able to pay all its short-term debts with the most liquid assets. +2
The TTM is 7.082. The company is very able to pay all its short-term debts with the most liquid assets. +2

Trends

Current period		Compared to		+/-
MRQ	7.060	TTM	7.082	-0.022
TTM	7.082	YOY	7.041	+0.042
TTM	7.082	5Y	5.019	+2.064
5Y	5.019	10Y	4.621	+0.398

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	7.060	1.098	+5.962
TTM	7.082	1.127	+5.955
YOY	7.041	1.306	+5.735
5Y	5.019	1.430	+3.589
10Y	4.621	1.533	+3.088

Measures if Lemaitre is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Lemaitre can pay off its short term debts. This shows if Lemaitre can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Lemaitre is 7.06. This means that Lemaitre can pay off $7.06 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 1.10.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Lemaitre

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Lemaitre: (105,074 + 80,805 +25,064) / 29,879 = 7.06

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of LeMaitre Vascular Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Lemaitre assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Lemaitre to Medical Instruments & Supplies industry mean.
A Debt to Asset Ratio of 0.14 means that Lemaitre assets are financed with 14.1% credit (debt) and the remaining percentage (100% - 14.1%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of LeMaitre Vascular Inc:

The MRQ is 0.141. The company is very able to pay all its debts by selling its assets. +2
The TTM is 0.134. The company is very able to pay all its debts by selling its assets. +2

Trends

Current period		Compared to		+/-
MRQ	0.141	TTM	0.134	+0.007
TTM	0.134	YOY	0.132	+0.002
TTM	0.134	5Y	0.193	-0.059
5Y	0.193	10Y	0.169	+0.025

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.141	0.357	-0.216
TTM	0.134	0.360	-0.226
YOY	0.132	0.353	-0.221
5Y	0.193	0.365	-0.172
10Y	0.169	0.371	-0.202

Measures how much % of Lemaitre assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Lemaitre than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Lemaitre to Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Lemaitre is 0.14. This means means that Lemaitre is financed with 14.1% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Medical Instruments & Supplies industry is 230.2%.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Lemaitre has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Lemaitre

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
48,878 \ 346,778 = 14.1% or 0.14.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Lemaitre is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
A Debt to Equity ratio of 16.4% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of LeMaitre Vascular Inc:

The MRQ is 0.164. The company is very able to pay all its debts with equity. +2
The TTM is 0.155. The company is very able to pay all its debts with equity. +2

Trends

Current period		Compared to		+/-
MRQ	0.164	TTM	0.155	+0.009
TTM	0.155	YOY	0.152	+0.003
TTM	0.155	5Y	0.256	-0.101
5Y	0.256	10Y	0.212	+0.044

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
MRQ	0.164	0.541	-0.377
TTM	0.155	0.561	-0.406
YOY	0.152	0.551	-0.399
5Y	0.256	0.653	-0.397
10Y	0.212	0.669	-0.457

Measures if Lemaitre is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Lemaitre is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Lemaitre is 0.16. This means that Lemaitre can pay off $0.16 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 0.54.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Lemaitre

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
48,878 \ 297,900 = 0.16 or 16.4%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of LeMaitre Vascular Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lemaitre generates.

Above 15 is considered overpriced but always compare Lemaitre to the Medical Instruments & Supplies industry mean.
A PE ratio of 37.65 means the investor is paying $37.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of LeMaitre Vascular Inc:

The EOD is 41.781. Based on the earnings, the company is overpriced. -1
The MRQ is 37.648. Based on the earnings, the company is overpriced. -1
The TTM is 43.170. Based on the earnings, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	41.781	MRQ	37.648	+4.132
MRQ	37.648	TTM	43.170	-5.522
TTM	43.170	YOY	53.222	-10.051
TTM	43.170	5Y	43.464	-0.294
5Y	43.464	10Y	34.074	+9.390

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	41.781	14.408	+27.373
MRQ	37.648	15.934	+21.714
TTM	43.170	16.376	+26.794
YOY	53.222	22.147	+31.075
5Y	43.464	20.830	+22.634
10Y	34.074	25.069	+9.005

Measures how much money you pay for each share for every $1 in earnings Lemaitre generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Lemaitre to the Medical Instruments & Supplies industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Lemaitre is 37.65. This means the investor is paying $37.65 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Medical Instruments & Supplies industry is 15.93.
What is the trend?
The trend is important because it shows you how Lemaitre is performing over time. The most recent quarter might be important if Lemaitre released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Lemaitre up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Lemaitre

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 22,459 = EPS
PE ratio MRQ = 37.65

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of LeMaitre Vascular Inc:

The EOD is 37.359. Based on how much money comes from the company's main activities, the company is fair priced.
The MRQ is 33.664. Based on how much money comes from the company's main activities, the company is fair priced.
The TTM is 508.153. Based on how much money comes from the company's main activities, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	37.359	MRQ	33.664	+3.695
MRQ	33.664	TTM	508.153	-474.489
TTM	508.153	YOY	56.312	+451.841
TTM	508.153	5Y	145.024	+363.128
5Y	145.024	10Y	91.901	+53.123

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	37.359	9.511	+27.848
MRQ	33.664	9.241	+24.423
TTM	508.153	0.922	+507.231
YOY	56.312	3.453	+52.859
5Y	145.024	5.897	+139.127
10Y	91.901	-0.177	+92.078

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Lemaitre is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
A PB ratio of 4.28 means the investor is paying $4.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of LeMaitre Vascular Inc:

The EOD is 4.749. Based on the equity, the company is fair priced.
The MRQ is 4.279. Based on the equity, the company is fair priced.
The TTM is 4.509. Based on the equity, the company is fair priced.

Trends

Current period		Compared to		+/-
EOD	4.749	MRQ	4.279	+0.470
MRQ	4.279	TTM	4.509	-0.230
TTM	4.509	YOY	4.034	+0.476
TTM	4.509	5Y	4.736	-0.226
5Y	4.736	10Y	4.803	-0.067

Compared to industry (Medical Instruments & Supplies)

Period	Company	Industry (mean)	+/-
EOD	4.749	2.448	+2.301
MRQ	4.279	2.753	+1.526
TTM	4.509	2.691	+1.818
YOY	4.034	3.294	+0.740
5Y	4.736	3.563	+1.173
10Y	4.803	4.227	+0.576

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of LeMaitre Vascular Inc.

3.1. Institutions holding LeMaitre Vascular Inc

Institutions are holding 91.044% of the shares of LeMaitre Vascular Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	BlackRock Inc	14.7614	0.0048	3297277	23912	0.7305
2023-12-31	Conestoga Capital Advisors, LLC	8.6312	1.6421	1927971	10390	0.5418
2023-12-31	Vanguard Group Inc	6.934	0.0019	1548870	38303	2.5357
2023-12-31	Copeland Capital Management, LLC	5.6406	1.4335	1259961	28720	2.3326
2023-12-31	Ranger Investment Management LP	4.0851	3.1403	912503	13681	1.5221
2023-12-31	Geneva Capital Management	4.0503	0.9698	904724	-1904	-0.21
2023-12-31	State Street Corporation	3.5666	0.0022	796687	14742	1.8853
2023-12-31	Dimensional Fund Advisors, Inc.	3.0029	0.0111	670761	783	0.1169
2023-12-31	Congress Asset Management Company, LLP	2.6622	0.2657	594672	86293	16.9741
2023-12-31	Geode Capital Management, LLC	2.0528	0.0027	458538	20611	4.7065
2023-12-31	Cramer Rosenthal McGlynn LLC	1.554	1.0705	347130	189839	120.6929
2023-12-31	Northern Trust Corp	1.3832	0.0032	308962	3519	1.1521
2023-12-31	Morgan Stanley - Brokerage Accounts	1.319	0.0015	294624	41615	16.448
2023-12-31	Ameriprise Financial Inc	1.2778	0.0049	285422	22149	8.4129
2023-12-31	Kennedy Capital Management Inc	1.0584	0.2931	236409	-26736	-10.1602
2023-12-31	Rice Hall James & Associates, LLC	1.0397	0.7633	232237	-15481	-6.2494
2023-12-31	Awm Investment Company Inc	1.0297	1.7173	230000	0	0
2023-12-31	Summit Creek Advisors LLC	1.023	1.7356	228501	62737	37.8472
2023-12-31	Bank of New York Mellon Corp	0.968	0.0025	216235	-23091	-9.6483
2023-12-31	Envestnet Asset Management Inc	0.9122	0.0048	203753	203753	0
Total		66.9521	13.0708	14955237	+693835	+4.6%

3.2. Funds holding LeMaitre Vascular Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	Conestoga Small Cap Investors	6.1803	2.3812	1380496	15200	1.1133
2024-03-28	iShares Core S&P Small-Cap ETF	5.9917	0.1105	1338388	-4963	-0.3694
2024-02-29	Vanguard Total Stock Mkt Idx Inv	2.7989	0.0028	625200	0	0
2024-03-31	Ranger Small Cap	2.7616	3.0731	616871	-96304	-13.5036
2023-12-31	Conestoga Small Cap Growth	2.4777	1.9285	553460	32256	6.1887
2024-03-28	iShares Russell 2000 ETF	2.1438	0.0485	478860	231	0.0483
2024-02-29	Congress Small Cap Growth Institutional	1.7907	2.7774	400000	0	0
2024-02-29	Nationwide Geneva Small Cap Gr Instl Svc	1.4476	1.4123	323353	-218	-0.0674
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.3013	0.0199	290676	-316	-0.1086
2024-01-31	Fidelity Small Cap Index	0.8962	0.0469	200194	3277	1.6642
2023-12-31	Ranger Micro Cap	0.892	4.8604	199240	199240	0
2024-03-28	iShares S&P Small-Cap 600 Growth ETF	0.8671	0.2174	193684	0	0
2024-03-28	SPDR® Portfolio S&P 600 Sm Cap ETF	0.7936	0.1119	177273	180	0.1016
2024-02-29	DFA US Micro Cap I	0.7676	0.1674	171467	0	0
2024-03-28	iShares Russell 2000 Growth ETF	0.7654	0.0974	170961	-199	-0.1163
2024-02-29	DFA US Small Cap I	0.7224	0.0728	161360	0	0
2024-02-29	Vanguard Tax-Managed Small Cap Adm	0.6997	0.1231	156299	0	0
2024-03-28	iShares US Medical Devices ETF	0.619	0.1593	138276	0	0
2024-02-29	Conestoga Small Cap Growth Cllctv A	0.615	2.4579	137381	-2900	-2.0673
2024-02-29	Multi-Manager Small Cap Eq Strat Inst	0.5967	0.6131	133291	0	0
Total		35.1283	20.6818	7846730	+145484	+1.9%

3.3. Insider Transactions

Insiders are holding 10.208% of the shares of LeMaitre Vascular Inc.

Date	Owner	Type	Amount	Price
2024-03-07	John A Roush	SELL	7500	69
2024-03-05	Lawrence J Jasinski	SELL	5110	67.5
2024-03-04	George W Lemaitre	SELL	36600	68.03
2024-02-29	George W Lemaitre	SELL	27859	69.73
2024-02-29	Joseph P Pellegrino Jr	SELL	36967	69.76
2023-12-11	George W Lemaitre	SELL	22288	54.42
2023-12-07	George W Lemaitre	SELL	24869	54.71
2023-06-02	Bridget A Ross	SELL	5000	64.24
2023-05-19	George W Lemaitre	SELL	7098	62.67
2023-05-17	George W Lemaitre	SELL	2176	64.06
2023-05-09	John A Roush	SELL	7500	65.74
2023-05-04	David B Roberts	SELL	34989	63.44
2023-05-03	George W Lemaitre	SELL	94900	63.48

4. Summary

4.1. Key Performance Indicators

The key performance indicators of LeMaitre Vascular Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	0.425	0.314	+35%	0.157	+170%	0.372	+14%	0.268	+58%
Book Value Per Share	-	-	13.264	12.755	+4%	11.699	+13%	9.508	+40%	6.750	+97%
Current Ratio	-	-	6.321	6.560	-4%	6.751	-6%	5.382	+17%	5.562	+14%
Debt To Asset Ratio	-	-	0.141	0.134	+5%	0.132	+7%	0.193	-27%	0.169	-16%
Debt To Equity Ratio	-	-	0.164	0.155	+6%	0.152	+8%	0.256	-36%	0.212	-23%
Dividend Per Share	-	-	0.139	0.139	+0%	0.123	+13%	0.109	+28%	0.078	+78%
Eps	-	-	0.377	0.335	+12%	0.231	+63%	0.261	+44%	0.200	+88%
Free Cash Flow Per Share	-	-	0.422	0.328	+28%	0.248	+70%	0.277	+52%	0.206	+104%
Free Cash Flow To Equity Per Share	-	-	0.302	0.249	+21%	0.145	+109%	0.333	-9%	0.234	+29%
Gross Profit Margin	-	-	-0.213	-0.392	+84%	-0.670	+215%	-0.436	+105%	-0.128	-40%
Intrinsic Value_10Y_max	-	-	16.829	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-1.132	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	1.288	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	0.670	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	4.175	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	1.347	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	7.426	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	1.287	-	-	-	-	-	-	-	-
Market Cap	1407020228.000	+9%	1274772840.000	1289934171.000	-1%	1053869096.000	+21%	989865192.200	+29%	725519511.700	+76%
Net Profit Margin	-	-	0.173	0.155	+11%	0.128	+35%	0.154	+12%	0.143	+21%
Operating Margin	-	-	0.208	0.189	+10%	0.130	+60%	0.154	+35%	0.132	+57%
Operating Ratio	-	-	0.792	0.808	-2%	0.815	-3%	0.799	-1%	0.817	-3%
Pb Ratio	4.749	+10%	4.279	4.509	-5%	4.034	+6%	4.736	-10%	4.803	-11%
Pe Ratio	41.781	+10%	37.648	43.170	-13%	53.222	-29%	43.464	-13%	34.074	+10%
Price Per Share	62.990	+10%	56.760	57.498	-1%	47.180	+20%	44.265	+28%	32.455	+75%
Price To Free Cash Flow Ratio	37.359	+10%	33.664	508.153	-93%	56.312	-40%	145.024	-77%	91.901	-63%
Price To Total Gains Ratio	111.732	+10%	100.681	130.631	-23%	199.660	-50%	134.577	-25%	90.639	+11%
Quick Ratio	-	-	7.060	7.082	0%	7.041	+0%	5.019	+41%	4.621	+53%
Return On Assets	-	-	0.024	0.023	+7%	0.017	+42%	0.023	+8%	0.025	-3%
Return On Equity	-	-	0.028	0.026	+8%	0.020	+44%	0.029	-1%	0.030	-7%
Total Gains Per Share	-	-	0.564	0.453	+24%	0.280	+101%	0.480	+17%	0.346	+63%
Usd Book Value	-	-	297900000.000	286132250.000	+4%	261317000.000	+14%	212622850.000	+40%	150887750.000	+97%
Usd Book Value Change Per Share	-	-	0.425	0.314	+35%	0.157	+170%	0.372	+14%	0.268	+58%
Usd Book Value Per Share	-	-	13.264	12.755	+4%	11.699	+13%	9.508	+40%	6.750	+97%
Usd Dividend Per Share	-	-	0.139	0.139	+0%	0.123	+13%	0.109	+28%	0.078	+78%
Usd Eps	-	-	0.377	0.335	+12%	0.231	+63%	0.261	+44%	0.200	+88%
Usd Free Cash Flow	-	-	9467000.000	7371500.000	+28%	5537250.000	+71%	6204550.000	+53%	4612950.000	+105%
Usd Free Cash Flow Per Share	-	-	0.422	0.328	+28%	0.248	+70%	0.277	+52%	0.206	+104%
Usd Free Cash Flow To Equity Per Share	-	-	0.302	0.249	+21%	0.145	+109%	0.333	-9%	0.234	+29%
Usd Market Cap	1407020228.000	+9%	1274772840.000	1289934171.000	-1%	1053869096.000	+21%	989865192.200	+29%	725519511.700	+76%
Usd Price Per Share	62.990	+10%	56.760	57.498	-1%	47.180	+20%	44.265	+28%	32.455	+75%
Usd Profit	-	-	8465000.000	7526250.000	+12%	5159000.000	+64%	5840100.000	+45%	4479625.000	+89%
Usd Revenue	-	-	48883000.000	48371000.000	+1%	40412750.000	+21%	37807850.000	+29%	30029800.000	+63%
Usd Total Gains Per Share	-	-	0.564	0.453	+24%	0.280	+101%	0.480	+17%	0.346	+63%
	EOD	+4 -4	MRQ	TTM	+28 -8	YOY	+30 -6	5Y	+31 -5	10Y	+31 -5

4.2. Fundamental Score

Let's check the fundamental score of LeMaitre Vascular Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	41.781
Price to Book Ratio (EOD)	Between	0-1	4.749
Net Profit Margin (MRQ)	Greater than	0	0.173
Operating Margin (MRQ)	Greater than	0	0.208
Quick Ratio (MRQ)	Greater than	1	7.060
Current Ratio (MRQ)	Greater than	1	6.321
Debt to Asset Ratio (MRQ)	Less than	1	0.141
Debt to Equity Ratio (MRQ)	Less than	1	0.164
Return on Equity (MRQ)	Greater than	0.15	0.028
Return on Assets (MRQ)	Greater than	0.05	0.024
Total			6/10 (60.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of LeMaitre Vascular Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	42.907
Ma 20	Greater than	Ma 50	64.466
Ma 50	Greater than	Ma 100	65.171
Ma 100	Greater than	Ma 200	60.973
Open	Greater than	Close	63.500
Total			3/5 (60.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

		2022-12-31		2023-03-31		2023-06-30		2023-09-30		2023-12-31
Long-term Assets Other		991	1,083	2,074	857	2,931	221	3,152	-35,376	-32,224

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	346,778
Total Liabilities	48,878
Total Stockholder Equity	297,900

	As reported
Total Liabilities	48,878
Total Stockholder Equity	+ 297,900
Total Assets	= 346,778

Assets

Total Assets	346,778
Total Current Assets	188,851
Long-term Assets	157,927

Total Current Assets

Total Current Assets (as reported)	188,851
Cash And Cash Equivalents	24,269
Short-term Investments	80,805
Net Receivables	25,064
Inventory	52,333
Other Current Assets	6,380
Total Current Assets (calculated)	188,851
+/-	0

Long-term Assets

Long-term Assets (as reported)	157,927
Property Plant Equipment	39,781
Goodwill	65,945
Intangible Assets	41,711
Long-term Assets (calculated)	147,437
+/-	10,490

Liabilities & Shareholders' Equity

Total Current Liabilities	29,879
Long-term Liabilities	18,999
Total Stockholder Equity	297,900

Total Current Liabilities

Total Current Liabilities (as reported)	29,879
Short-term Debt	2,471
Accounts payable	3,734
Other Current Liabilities	23,284
Total Current Liabilities (calculated)	29,489
+/-	390

Long-term Liabilities

Long-term Liabilities (as reported)	18,999
Capital Lease Obligations	19,095
Long-term Liabilities (calculated)	19,095
+/-	96

Total Stockholder Equity

Total Stockholder Equity (as reported)	297,900
Common Stock	239
Retained Earnings	115,430
Accumulated Other Comprehensive Income	-4,625
Other Stockholders Equity	186,856
Total Stockholder Equity (calculated)	297,900
+/-	0

Other

Capital Stock	239
Cash and Short Term Investments	105,074
Common Stock Shares Outstanding	22,459
Current Deferred Revenue	390
Liabilities and Stockholders Equity	346,778
Net Debt	-5,174
Net Invested Capital	297,900
Net Working Capital	164,719
Property Plant and Equipment Gross	61,269
Short Long Term Debt Total	19,095

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

> Total Assets

0
0
0
20,501
0
0
0
25,068
26,461
27,681
27,649
56,963
55,964
56,228
57,095
61,151
56,785
56,028
53,571
54,399
50,890
53,703
56,319
56,906
56,951
58,049
61,438
63,274
61,052
61,691
63,024
59,687
59,389
59,999
61,192
63,060
63,246
63,675
66,596
70,492
68,718
80,536
83,405
81,492
79,573
83,237
86,612
90,704
93,384
95,529
101,306
101,924
106,522
112,054
121,269
126,323
129,410
137,100
144,327
153,088
160,252
162,661
170,014
188,339
184,557
255,717
261,569
252,810
247,369
246,505
289,473
292,802
292,453
299,425
302,048
310,476
314,866
326,467
334,012
346,778

346,778

334,012

326,467

314,866

310,476

302,048

299,425

292,453

292,802

289,473

246,505

247,369

252,810

261,569

255,717

184,557

188,339

170,014

162,661

160,252

153,088

144,327

137,100

129,410

126,323

121,269

112,054

106,522

101,924

101,306

95,529

93,384

90,704

86,612

83,237

79,573

81,492

83,405

80,536

68,718

70,492

66,596

63,675

63,246

63,060

61,192

59,999

59,389

59,687

63,024

61,691

61,052

63,274

61,438

58,049

56,951

56,906

56,319

53,703

50,890

54,399

53,571

56,028

56,785

61,151

57,095

56,228

55,964

56,963

27,649

27,681

26,461

25,068

20,501

> Total Current Assets

0
0
0
9,102
0
0
0
10,817
11,426
11,997
12,073
43,641
42,731
42,692
41,100
42,060
37,911
37,524
35,960
37,116
33,042
35,986
38,593
39,550
39,838
41,194
44,156
42,911
41,070
41,616
42,892
39,687
39,618
40,668
42,191
39,351
38,728
38,835
39,038
41,725
40,335
53,002
49,434
48,588
47,797
50,309
53,977
58,184
59,742
62,422
68,235
59,027
62,504
68,089
75,642
80,311
84,008
92,364
86,811
94,017
95,418
98,159
99,695
92,090
89,722
91,869
102,252
94,263
90,657
90,020
134,016
139,883
141,411
148,486
153,142
161,733
164,768
174,490
182,184
188,851

188,851

182,184

174,490

164,768

161,733

153,142

148,486

141,411

139,883

134,016

90,020

90,657

94,263

102,252

91,869

89,722

92,090

99,695

98,159

95,418

94,017

86,811

92,364

84,008

80,311

75,642

68,089

62,504

59,027

68,235

62,422

59,742

58,184

53,977

50,309

47,797

48,588

49,434

53,002

40,335

41,725

39,038

38,835

38,728

39,351

42,191

40,668

39,618

39,687

42,892

41,616

41,070

42,911

44,156

41,194

39,838

39,550

38,593

35,986

33,042

37,116

35,960

37,524

37,911

42,060

41,100

42,692

42,731

43,641

12,073

11,997

11,426

10,817

9,102

Cash And Cash Equivalents

0
0
0
724
0
0
0
817
469
666
453
15,391
13,241
12,474
7,752
6,691
5,444
10,648
13,163
15,895
14,093
16,740
19,809
23,192
23,662
25,608
27,453
22,614
19,103
21,405
23,087
20,132
19,622
20,162
20,639
16,448
15,302
14,910
13,626
14,711
12,504
23,512
18,354
18,692
17,025
19,430
23,629
27,451
25,941
29,315
34,650
24,288
25,810
30,120
37,514
19,096
22,781
19,638
20,104
26,318
14,766
13,264
11,719
11,786
10,944
19,976
29,279
26,764
23,525
21,541
17,369
13,855
15,560
20,788
16,913
19,134
16,677
19,488
18,051
24,269

24,269

18,051

19,488

16,677

19,134

16,913

20,788

15,560

13,855

17,369

21,541

23,525

26,764

29,279

19,976

10,944

11,786

11,719

13,264

14,766

26,318

20,104

19,638

22,781

19,096

37,514

30,120

25,810

24,288

34,650

29,315

25,941

27,451

23,629

19,430

17,025

18,692

18,354

23,512

12,504

14,711

13,626

14,910

15,302

16,448

20,639

20,162

19,622

20,132

23,087

21,405

19,103

22,614

27,453

25,608

23,662

23,192

19,809

16,740

14,093

15,895

13,163

10,648

5,444

6,691

7,752

12,474

13,241

15,391

453

666

469

817

724

Short-term Investments

0
0
0
300
0
0
0
0
0
0
0
15,417
15,379
15,459
17,885
16,198
12,358
7,623
6,000
5,359
3,171
3,078
2,916
808
436
342
169
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,564
22,613
33,298
25,523
21,668
32,691
34,979
33,177
20,894
19,687
5,074
5,097
214
214
215
49,710
56,104
55,322
54,895
62,826
63,557
64,328
70,689
78,967
80,805

80,805

78,967

70,689

64,328

63,557

62,826

54,895

55,322

56,104

49,710

215

214

5,097

5,074

19,687

20,894

33,177

34,979

32,691

21,668

25,523

33,298

22,613

22,564

169

342

436

808

2,916

3,078

3,171

5,359

6,000

7,623

12,358

16,198

17,885

15,459

15,379

15,417

300

Net Receivables

0
0
0
3,745
0
0
0
4,207
4,826
4,925
4,808
5,060
5,687
6,080
6,221
7,020
7,166
7,148
6,788
7,244
7,164
7,767
7,838
7,778
8,054
7,861
8,166
8,475
9,371
9,066
8,853
8,541
8,690
8,801
8,474
9,048
9,357
9,714
9,273
10,590
10,494
11,373
10,590
10,803
11,877
12,242
11,339
11,971
13,017
12,838
12,176
13,191
14,090
14,590
13,553
15,000
14,510
15,230
13,015
15,721
15,460
15,548
14,878
16,572
16,630
17,696
19,625
19,552
20,126
20,741
19,501
19,631
21,386
21,542
20,094
22,040
25,365
26,406
23,882
25,064

25,064

23,882

26,406

25,365

22,040

20,094

21,542

21,386

19,631

19,501

20,741

20,126

19,552

19,625

17,696

16,630

16,572

14,878

15,548

15,460

15,721

13,015

15,230

14,510

15,000

13,553

14,590

14,090

13,191

12,176

12,838

13,017

11,971

11,339

12,242

11,877

10,803

10,590

11,373

10,494

10,590

9,273

9,714

9,357

9,048

8,474

8,801

8,690

8,541

8,853

9,066

9,371

8,475

8,166

7,861

8,054

7,778

7,838

7,767

7,164

7,244

6,788

7,148

7,166

7,020

6,221

6,080

5,687

5,060

4,808

4,925

4,826

4,207

3,745

Other Current Assets

0
0
0
429
0
0
0
646
739
731
801
1,692
1,315
1,344
1,096
2,562
2,677
2,447
1,906
1,659
1,449
1,401
1,535
1,274
1,434
1,243
1,458
3,447
3,478
3,187
3,702
3,011
3,009
2,578
2,948
2,996
2,804
2,557
3,057
3,169
3,151
3,122
3,565
2,379
2,439
2,856
3,089
3,557
2,887
3,308
3,979
4,587
4,716
5,254
5,483
4,428
3,607
3,728
5,718
4,739
5,097
-1
7,637
8,210
7,089
8,651
8,730
8,568
7,555
8,373
8,638
4,189
7,795
9,501
10,875
6,731
4,619
4,076
5,097
6,380

6,380

5,097

4,076

4,619

6,731

10,875

9,501

7,795

4,189

8,638

8,373

7,555

8,568

8,730

8,651

7,089

8,210

7,637

-1

5,097

4,739

5,718

3,728

3,607

4,428

5,483

5,254

4,716

4,587

3,979

3,308

2,887

3,557

3,089

2,856

2,439

2,379

3,565

3,122

3,151

3,169

3,057

2,557

2,804

2,996

2,948

2,578

3,009

3,011

3,702

3,187

3,478

3,447

1,458

1,243

1,434

1,274

1,535

1,401

1,449

1,659

1,906

2,447

2,677

2,562

1,096

1,344

1,315

1,692

801

731

739

646

429

> Long-term Assets

0
0
0
11,399
0
0
0
14,251
15,035
15,684
15,576
13,322
13,233
13,536
15,995
19,091
18,874
18,504
17,611
17,283
17,848
17,717
17,726
17,356
17,113
16,855
17,282
20,363
19,982
20,075
20,132
20,000
19,771
19,331
19,001
23,709
24,518
24,840
27,558
28,767
28,383
27,534
33,971
32,904
31,776
32,928
32,635
32,520
33,642
33,107
33,071
42,897
44,018
43,965
45,627
46,012
45,402
44,736
57,516
59,071
64,834
64,502
70,319
96,249
94,835
163,848
159,317
158,547
156,712
156,485
155,457
152,919
151,042
150,939
148,906
148,743
150,098
151,977
151,828
157,927

157,927

151,828

151,977

150,098

148,743

148,906

150,939

151,042

152,919

155,457

156,485

156,712

158,547

159,317

163,848

94,835

96,249

70,319

64,502

64,834

59,071

57,516

44,736

45,402

46,012

45,627

43,965

44,018

42,897

33,071

33,107

33,642

32,520

32,635

32,928

31,776

32,904

33,971

27,534

28,383

28,767

27,558

24,840

24,518

23,709

19,001

19,331

19,771

20,000

20,132

20,075

19,982

20,363

17,282

16,855

17,113

17,356

17,726

17,717

17,848

17,283

17,611

18,504

18,874

19,091

15,995

13,536

13,233

13,322

15,576

15,684

15,035

14,251

11,399

Property Plant Equipment

0
0
0
2,435
0
0
0
2,658
2,756
2,719
2,506
2,389
2,356
2,352
2,435
2,891
2,975
2,820
2,524
2,327
2,143
2,098
2,231
2,101
2,144
2,233
2,645
3,806
4,115
4,027
4,394
4,661
4,631
4,607
4,490
4,544
5,379
5,836
5,984
5,810
5,807
5,474
7,196
6,878
6,594
6,610
6,788
7,022
7,355
7,324
7,490
8,012
9,279
9,544
11,367
12,378
12,170
12,235
12,197
14,102
20,375
20,591
20,078
30,062
29,674
32,419
30,506
31,102
30,678
32,038
32,661
32,130
31,370
32,043
31,136
33,535
34,769
37,021
37,207
39,781

39,781

37,207

37,021

34,769

33,535

31,136

32,043

31,370

32,130

32,661

32,038

30,678

31,102

30,506

32,419

29,674

30,062

20,078

20,591

20,375

14,102

12,197

12,235

12,170

12,378

11,367

9,544

9,279

8,012

7,490

7,324

7,355

7,022

6,788

6,610

6,594

6,878

7,196

5,474

5,807

5,810

5,984

5,836

5,379

4,544

4,490

4,607

4,631

4,661

4,394

4,027

4,115

3,806

2,645

2,233

2,144

2,101

2,231

2,098

2,143

2,327

2,524

2,820

2,975

2,891

2,435

2,352

2,356

2,389

2,506

2,719

2,756

2,658

2,435

Goodwill

0
0
0
6,709
0
0
0
8,853
8,853
8,853
8,853
8,853
8,853
9,161
11,096
10,942
10,959
10,959
10,922
11,022
11,022
11,022
11,022
11,022
11,022
11,022
11,022
11,917
11,917
11,917
11,917
11,917
11,917
11,917
11,917
13,749
13,749
13,749
15,031
15,031
15,031
15,031
17,441
17,281
17,132
17,900
17,717
17,789
18,192
18,150
18,206
23,426
23,629
23,645
23,850
23,844
23,810
23,602
31,544
29,868
29,880
29,860
32,102
41,656
39,773
66,151
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945
65,945

65,945

66,151

39,773

41,656

32,102

29,860

29,880

29,868

31,544

23,602

23,810

23,844

23,850

23,645

23,629

23,426

18,206

18,150

18,192

17,789

17,717

17,900

17,132

17,281

17,441

15,031

13,749

11,917

11,022

10,922

10,959

10,942

11,096

9,161

8,853

6,709

Intangible Assets

0
0
0
1,626
0
0
0
2,412
2,328
1,980
1,937
1,930
1,861
1,864
2,302
3,886
3,507
3,349
3,088
2,883
3,717
3,631
3,502
3,316
3,105
2,768
2,737
3,686
3,458
3,535
3,243
2,985
2,800
2,568
2,415
5,191
4,965
4,840
6,127
6,144
5,758
5,250
7,635
7,157
6,619
6,941
6,656
6,336
6,660
6,211
5,872
9,897
9,524
9,083
8,669
8,234
7,806
7,358
12,248
13,692
13,179
12,632
16,765
23,188
24,059
63,165
60,539
58,905
57,339
55,777
54,230
52,710
51,194
49,598
48,063
46,527
45,508
43,999
43,199
41,711

41,711

43,199

43,999

45,508

46,527

48,063

49,598

51,194

52,710

54,230

55,777

57,339

58,905

60,539

63,165

24,059

23,188

16,765

12,632

13,179

13,692

12,248

7,358

7,806

8,234

8,669

9,083

9,524

9,897

5,872

6,211

6,660

6,336

6,656

6,941

6,619

7,157

7,635

5,250

5,758

6,144

6,127

4,840

4,965

5,191

2,415

2,568

2,800

2,985

3,243

3,535

3,458

3,686

2,737

2,768

3,105

3,316

3,502

3,631

3,717

2,883

3,088

3,349

3,507

3,886

2,302

1,864

1,861

1,930

1,937

1,980

2,328

2,412

1,626

Other Assets

0
0
0
8,964
0
0
0
11,593
0
0
13,070
10,933
10,877
11,184
13,560
16,200
15,899
15,684
15,087
14,956
15,705
15,619
15,495
15,255
14,969
14,622
14,637
16,557
15,867
16,048
15,738
15,339
15,140
14,724
14,511
19,385
19,139
19,004
21,574
22,957
22,576
22,060
26,870
26,026
25,182
26,318
25,847
25,498
26,287
25,783
25,581
34,885
34,739
34,421
34,260
33,634
1,616
1,541
1,528
1,409
1,400
1,419
1,374
1,343
1,329
2,113
2,327
18,447
2,750
2,725
2,621
2,134
2,533
3,353
3,762
2,736
3,876
0
0
0

3,876

2,736

3,762

3,353

2,533

2,134

2,621

2,725

2,750

18,447

2,327

2,113

1,329

1,343

1,374

1,419

1,400

1,409

1,528

1,541

1,616

33,634

34,260

34,421

34,739

34,885

25,581

25,783

26,287

25,498

25,847

26,318

25,182

26,026

26,870

22,060

22,576

22,957

21,574

19,004

19,139

19,385

14,511

14,724

15,140

15,339

15,738

16,048

15,867

16,557

14,637

14,622

14,969

15,255

15,495

15,619

15,705

14,956

15,087

15,684

15,899

16,200

13,560

11,184

10,877

10,933

13,070

11,593

8,964

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147
136
6
7
6
6
273
262
259
258
1,615
1,619
1,610
1,620
1,418
1,263
1,309
1,306
1,205
1,265
1,245
1,327
1,399
1,421
1,514
1,562
1,378
1,419
1,347
1,336
0
0
0
1,164
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,164

1,336

1,347

1,419

1,378

1,562

1,514

1,421

1,399

1,327

1,245

1,265

1,205

1,306

1,309

1,263

1,418

1,620

1,610

1,619

1,615

258

259

262

273

136

147

> Total Liabilities

0
0
0
5,688
0
0
0
6,532
7,602
16,498
16,190
6,264
5,774
5,732
7,590
12,565
10,098
10,337
8,344
8,651
6,895
8,062
8,966
8,693
8,373
8,872
10,138
10,918
8,742
8,887
10,379
7,599
7,343
8,026
9,286
10,172
9,908
9,544
11,144
13,930
12,482
12,753
16,286
13,285
11,646
12,798
12,426
12,820
12,760
12,679
14,616
14,424
14,904
13,743
15,156
16,553
15,940
16,356
18,980
22,853
27,164
25,124
27,698
40,196
35,722
103,088
100,586
80,238
69,844
60,672
40,425
38,651
34,666
41,392
40,801
42,275
40,701
42,640
45,375
48,878

48,878

45,375

42,640

40,701

42,275

40,801

41,392

34,666

38,651

40,425

60,672

69,844

80,238

100,586

103,088

35,722

40,196

27,698

25,124

27,164

22,853

18,980

16,356

15,940

16,553

15,156

13,743

14,904

14,424

14,616

12,679

12,760

12,820

12,426

12,798

11,646

13,285

16,286

12,753

12,482

13,930

11,144

9,544

9,908

10,172

9,286

8,026

7,343

7,599

10,379

8,887

8,742

10,918

10,138

8,872

8,373

8,693

8,966

8,062

6,895

8,651

8,344

10,337

10,098

12,565

7,590

5,732

5,774

6,264

16,190

16,498

7,602

6,532

5,688

> Total Current Liabilities

0
0
0
3,806
0
0
0
5,095
6,325
8,629
5,860
5,378
4,908
4,873
6,740
10,339
8,327
8,485
6,484
6,933
5,121
6,212
6,895
6,548
6,232
6,702
7,812
10,389
8,217
8,362
9,861
6,539
6,286
6,936
8,195
8,394
7,874
7,456
9,228
10,220
8,709
9,012
12,486
10,041
8,388
9,239
8,833
10,368
10,164
10,136
12,064
10,482
10,765
9,397
12,110
13,189
12,642
13,115
15,754
19,758
19,385
17,422
19,323
20,858
16,594
44,357
44,446
25,145
22,300
21,480
22,114
21,813
18,267
23,405
23,439
25,329
23,904
25,855
29,029
29,879

29,879

29,029

25,855

23,904

25,329

23,439

23,405

18,267

21,813

22,114

21,480

22,300

25,145

44,446

44,357

16,594

20,858

19,323

17,422

19,385

19,758

15,754

13,115

12,642

13,189

12,110

9,397

10,765

10,482

12,064

10,136

10,164

10,368

8,833

9,239

8,388

10,041

12,486

9,012

8,709

10,220

9,228

7,456

7,874

8,394

8,195

6,936

6,286

6,539

9,861

8,362

8,217

10,389

7,812

6,702

6,232

6,548

6,895

6,212

5,121

6,933

6,484

8,485

8,327

10,339

6,740

4,873

4,908

5,378

5,860

8,629

6,325

5,095

3,806

Short-term Debt

0
0
0
472
0
0
0
1,232
1,607
3,180
1,558
32
6
0
0
262
262
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,335
10,254
15,295
1,438
1,698
1,666
1,757
1,703
28,767
25,056
4,454
4,598
4,954
1,901
1,870
1,872
1,794
1,828
1,886
2,057
2,358
2,749
2,471

2,471

2,749

2,358

2,057

1,886

1,828

1,794

1,872

1,870

1,901

4,954

4,598

4,454

25,056

28,767

1,703

1,757

1,666

1,698

1,438

15,295

10,254

10,335

262

1,558

3,180

1,607

1,232

472

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,438
1,698
0
0
0
27,000
23,250
2,500
2,750
3,000
0
0
0
0
0
0
0
0
0
0

3,000

2,750

2,500

23,250

27,000

1,698

1,438

Accounts payable

0
0
0
466
0
0
0
265
726
828
629
818
1,181
1,311
1,349
2,565
2,536
2,108
814
606
1,052
1,233
1,043
1,136
1,483
1,072
1,425
1,320
1,726
1,199
1,276
981
825
937
879
1,060
929
1,011
748
1,235
1,040
1,021
1,021
1,127
1,128
1,293
931
1,366
1,773
1,550
1,148
1,217
2,220
1,574
1,617
1,543
1,440
1,657
1,627
1,732
2,381
1,427
1,670
2,604
1,381
1,237
2,168
2,394
2,561
2,059
3,137
2,340
2,194
2,844
2,848
2,903
3,371
3,519
4,371
3,734

3,734

4,371

3,519

3,371

2,903

2,848

2,844

2,194

2,340

3,137

2,059

2,561

2,394

2,168

1,237

1,381

2,604

1,670

1,427

2,381

1,732

1,627

1,657

1,440

1,543

1,617

1,574

2,220

1,217

1,148

1,550

1,773

1,366

931

1,293

1,128

1,127

1,021

1,040

1,235

748

1,011

929

1,060

879

937

825

981

1,276

1,199

1,726

1,320

1,425

1,072

1,483

1,136

1,043

1,233

1,052

606

814

2,108

2,536

2,565

1,349

1,311

1,181

818

629

828

726

265

466

Other Current Liabilities

0
0
0
276
0
0
0
3,598
3,992
4,621
3,673
4,528
3,721
3,562
5,391
851
5,791
6,377
5,670
6,327
4,069
4,979
5,852
5,412
4,749
5,630
6,387
9,069
6,491
7,163
8,585
5,558
5,461
5,999
7,316
7,334
6,945
6,445
8,480
8,985
7,669
7,991
11,465
8,914
7,260
7,946
7,902
9,002
8,391
8,586
10,916
9,265
8,545
7,823
10,493
11,646
11,202
172
3,121
2,179
15,198
14,109
2,597
2,476
2,495
2,517
2,543
772
776
701
616
1,271
14,201
18,767
18,763
20,540
18,476
651
121
23,284

23,284

121

651

18,476

20,540

18,763

18,767

14,201

1,271

616

701

776

772

2,543

2,517

2,495

2,476

2,597

14,109

15,198

2,179

3,121

172

11,202

11,646

10,493

7,823

8,545

9,265

10,916

8,586

8,391

9,002

7,902

7,946

7,260

8,914

11,465

7,991

7,669

8,985

8,480

6,445

6,945

7,334

7,316

5,999

5,461

5,558

8,585

7,163

6,491

9,069

6,387

5,630

4,749

5,412

5,852

4,979

4,069

6,327

5,670

6,377

5,791

851

5,391

3,562

3,721

4,528

3,673

4,621

3,992

3,598

276

> Long-term Liabilities

0
0
0
1,882
0
0
0
1,437
1,277
7,869
10,330
886
866
859
850
2,226
1,771
1,852
1,860
1,718
1,774
1,850
2,071
2,145
2,141
2,170
2,326
529
525
525
518
1,060
1,057
1,090
1,091
1,778
2,034
2,088
1,916
3,710
3,773
3,741
3,800
3,244
3,258
3,559
3,593
2,452
2,596
2,543
2,552
3,942
4,139
4,346
3,046
3,364
3,298
3,241
3,226
3,095
7,779
7,702
8,375
19,338
19,128
58,731
56,140
55,093
47,544
39,192
18,311
16,838
16,399
17,987
17,362
16,946
16,797
16,785
16,346
18,999

18,999

16,346

16,785

16,797

16,946

17,362

17,987

16,399

16,838

18,311

39,192

47,544

55,093

56,140

58,731

19,128

19,338

8,375

7,702

7,779

3,095

3,226

3,241

3,298

3,364

3,046

4,346

4,139

3,942

2,552

2,543

2,596

2,452

3,593

3,559

3,258

3,244

3,800

3,741

3,773

3,710

1,916

2,088

2,034

1,778

1,091

1,090

1,057

1,060

518

525

529

2,326

2,170

2,141

2,145

2,071

1,850

1,774

1,718

1,860

1,852

1,771

2,226

850

859

866

886

10,330

7,869

1,277

1,437

1,882

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,990
0
0
0
19,448
0
0
0
0
0
0
0
0
0
0

19,448

36,990

Deferred Long Term Asset Charges

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147
136
6
7
6
6
273
262
259
258
1,615
1,619
1,610
1,620
1,418
1,263
1,309
1,306
1,205
1,265
1,245
1,327
1,399
1,421
1,514
1,562
1,378
1,419
1,347
1,336
0
0
0
1,164
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

1,164

1,336

1,347

1,419

1,378

1,562

1,514

1,421

1,399

1,327

1,245

1,265

1,205

1,306

1,309

1,263

1,418

1,620

1,610

1,619

1,615

258

259

262

273

136

147

Other Liabilities

0
0
0
344
0
0
0
156
0
0
133
53
33
26
17
1,188
514
456
438
380
364
381
413
411
376
347
391
86
82
82
75
71
68
101
102
105
361
415
243
249
298
265
400
325
341
641
676
774
916
864
872
2,001
2,198
2,400
1,098
1,188
3,298
3,241
4,341
3,095
2,516
2,550
3,620
5,394
5,413
6,194
4,719
4,770
4,699
4,675
3,722
2,771
2,694
2,567
2,465
2,236
2,349
0
0
0

2,349

2,236

2,465

2,567

2,694

2,771

3,722

4,675

4,699

4,770

4,719

6,194

5,413

5,394

3,620

2,550

2,516

3,095

4,341

3,241

3,298

1,188

1,098

2,400

2,198

2,001

872

864

916

774

676

641

341

325

400

265

298

249

243

415

361

105

102

101

391

347

376

411

413

381

364

380

438

456

514

1,188

133

156

344

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
443
443
989
989
989
989
1,673
1,673
1,673
1,673
3,461
3,475
3,476
3,400
2,919
2,917
2,918
2,917
1,678
1,680
1,679
1,680
1,941
1,941
1,946
1,948
2,176
2,177
2,175
2,174
0
484
484
0
1,179
1,176
0
700
700
700
700
122
70
68
0
0
0
71
72
0
0

122

700

1,176

1,179

484

2,174

2,175

2,177

2,176

1,948

1,946

1,941

1,680

1,679

1,680

1,678

2,917

2,918

2,917

2,919

3,400

3,476

3,475

3,461

1,673

989

443

> Total Stockholder Equity

0
0
0
14,813
0
0
0
18,536
18,859
11,183
11,459
50,699
50,190
50,496
49,505
48,586
46,687
45,691
45,227
45,748
43,995
45,641
47,353
48,213
48,578
49,177
51,300
52,356
52,310
52,804
52,645
52,088
52,046
51,973
51,906
52,888
53,338
54,131
55,452
56,562
56,236
67,783
67,119
68,207
67,927
70,439
74,186
77,884
80,624
82,850
86,690
87,500
91,618
98,311
106,113
109,770
113,470
120,744
125,347
130,235
133,088
137,537
142,316
148,143
148,835
152,629
160,983
172,572
177,525
185,833
249,048
254,151
257,787
258,033
261,247
268,201
274,165
283,827
288,637
297,900

297,900

288,637

283,827

274,165

268,201

261,247

258,033

257,787

254,151

249,048

185,833

177,525

172,572

160,983

152,629

148,835

148,143

142,316

137,537

133,088

130,235

125,347

120,744

113,470

109,770

106,113

98,311

91,618

87,500

86,690

82,850

80,624

77,884

74,186

70,439

67,927

68,207

67,119

67,783

56,236

56,562

55,452

54,131

53,338

52,888

51,906

51,973

52,046

52,088

52,645

52,804

52,310

52,356

51,300

49,177

48,578

48,213

47,353

45,641

43,995

45,748

45,227

45,691

46,687

48,586

49,505

50,496

50,190

50,699

11,459

11,183

18,859

18,536

14,813

Common Stock

0
0
0
81
0
0
0
86
86
86
85
153
154
155
155
155
155
156
157
157
157
157
158
159
159
159
161
161
161
162
163
163
163
163
164
165
166
166
168
170
170
187
188
188
189
191
195
197
198
199
200
200
202
204
207
207
208
208
211
211
212
213
215
217
217
217
218
221
221
222
234
235
235
235
236
237
238
239
239
239

239

238

237

236

235

234

222

221

218

217

215

213

212

211

208

207

204

202

200

199

198

197

195

191

189

188

187

170

168

166

165

164

163

162

161

159

158

157

156

155

154

153

Retained Earnings Total Equity

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,000
-6,786
-6,440
-6,054
-5,230
-4,567
-3,869
-3,024
-2,134
-1,413
-667
-874
398
1,332
3,248
3,917
4,979
6,356
8,161
9,502
11,272
13,568
15,335
17,526
21,122
25,109
28,333
30,836
38,234
41,178
45,831
47,672
50,624
54,117
57,029
58,286
59,869
65,457
70,554
74,221
80,253
84,356
88,125
91,420
92,190
94,896
97,773
100,714
105,696
0
0

105,696

100,714

97,773

94,896

92,190

91,420

88,125

84,356

80,253

74,221

70,554

65,457

59,869

58,286

57,029

54,117

50,624

47,672

45,831

41,178

38,234

30,836

28,333

25,109

21,122

17,526

15,335

13,568

11,272

9,502

8,161

6,356

4,979

3,917

3,248

1,332

398

-874

-667

-1,413

-2,134

-3,024

-3,869

-4,567

-5,230

-6,054

-6,440

-6,786

-8,000

Accumulated Other Comprehensive Income

0
0
0
792
0
0
0
-151
-127
-32
38
73
139
68
123
291
698
371
-255
-272
-381
126
420
94
-457
-1,217
-361
-429
-132
-6
-460
-606
-313
-618
-500
-433
-728
-653
-343
-253
-226
-250
-1,628
-2,365
-3,961
-3,525
-4,033
-4,049
-3,120
-3,525
-3,213
-4,583
-3,963
-2,944
-2,280
-2,289
-2,006
-3,207
-3,482
-3,900
-4,092
-3,818
-4,894
-4,007
-5,525
-4,159
-3,009
-1,525
-2,463
-2,243
-2,636
-3,435
-4,624
-6,444
-8,127
-6,031
-5,572
-5,822
-6,705
-4,625

-4,625

-6,705

-5,822

-5,572

-6,031

-8,127

-6,444

-4,624

-3,435

-2,636

-2,243

-2,463

-1,525

-3,009

-4,159

-5,525

-4,007

-4,894

-3,818

-4,092

-3,900

-3,482

-3,207

-2,006

-2,289

-2,280

-2,944

-3,963

-4,583

-3,213

-3,525

-3,120

-4,049

-4,033

-3,525

-3,961

-2,365

-1,628

-250

-226

-253

-343

-653

-728

-433

-500

-618

-313

-606

-460

-6

-132

-429

-361

-1,217

-457

420

126

-381

-272

-255

371

698

291

123

139

-32

-127

-151

792

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
64,605
64,622
64,619
64,500
64,416
64,442
64,694
64,683
64,524
64,983
65,354
65,209
75,497
75,480
75,389
76,041
77,053
80,188
82,094
82,563
83,425
84,837
85,378
86,683
88,759
92,685
93,127
94,040
95,122
97,727
98,442
99,666
100,890
103,673
105,934
106,946
107,791
109,640
114,924
117,236
119,291
179,070
181,630
183,305
184,605
186,798
189,268
192,003
196,941
0
0

196,941

192,003

189,268

186,798

184,605

183,305

181,630

179,070

119,291

117,236

114,924

109,640

107,791

106,946

105,934

103,673

100,890

99,666

98,442

97,727

95,122

94,040

93,127

92,685

88,759

86,683

85,378

84,837

83,425

82,563

82,094

80,188

77,053

76,041

75,389

75,480

75,497

65,209

65,354

64,983

64,524

64,683

64,694

64,442

64,416

64,500

64,619

64,622

64,605

Treasury Stock

-13,046

-12,556

-12,553

-12,549

-12,404

-11,976

-11,690

-11,602

-11,323

-11,089

-11,032

-10,795

-10,372

-10,370

-10,349

-10,287

-9,613

-9,608

-8,830

-8,702

-8,521

-8,519

-8,520

-8,259

-8,253

-8,049

-8,043

-8,042

-8,003

-7,772

-7,759

-7,669

-7,633

-6,758

-6,250

-5,648

-4,894

-3,957

-3,811

-3,435

-2,234

-1,639

-1,239

-919

-413

-245

-235

-233

-204

-184

-175

-167

-85

-783

-222

Other Stockholders Equity

0
0
0
13,809
0
0
0
18,415
18,344
18,352
18,417
60,419
60,472
60,621
60,929
61,020
61,279
61,533
61,831
62,057
62,294
62,510
62,640
62,556
62,451
62,299
62,047
61,207
61,110
60,648
59,728
58,971
58,250
57,658
56,809
57,025
56,924
56,752
56,980
57,312
57,166
67,448
67,227
67,136
67,782
68,794
71,668
73,575
74,044
74,904
76,135
76,548
77,853
79,929
83,077
83,519
84,432
85,509
87,440
88,093
89,296
90,518
92,878
94,902
95,857
96,702
98,317
103,322
105,546
107,601
167,094
169,226
170,756
172,052
174,242
176,222
178,785
183,714
185,022
186,856

186,856

185,022

183,714

178,785

176,222

174,242

172,052

170,756

169,226

167,094

107,601

105,546

103,322

98,317

96,702

95,857

94,902

92,878

90,518

89,296

88,093

87,440

85,509

84,432

83,519

83,077

79,929

77,853

76,548

76,135

74,904

74,044

73,575

71,668

68,794

67,782

67,136

67,227

67,448

57,166

57,312

56,980

56,752

56,924

57,025

56,809

57,658

58,250

58,971

59,728

60,648

61,110

61,207

62,047

62,299

62,451

62,556

62,640

62,510

62,294

62,057

61,831

61,533

61,279

61,020

60,929

60,621

60,472

60,419

18,417

18,352

18,344

18,415

13,809

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31
Accounts Payable	3,734	2,903	2,340	2,394	2,604	1,732	1,543	1,217	1,366	1,127	1,235	1,060	981	1,320	1,136	606	2,565	818	265	466	-	-	-
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Accumulated Other Comprehensive Income	-4,625	-6,031	-3,435	-1,525	-4,007	-3,900	-2,289	-4,583	-4,049	-2,365	-253	-433	-606	-429	94	-272	291	73	-151	792	-	-	-
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Lease Obligations	19,095	16,596	15,937	16,745	15,712	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Stock	239	237	235	221	217	211	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Capital Surpluse	0	189,268	181,630	114,924	105,934	98,442	93,127	85,378	82,094	75,389	65,354	64,694	64,619	0	0	0	0	0	0	0	-	-	-
Cash	24,269	19,134	13,855	26,764	11,786	26,318	19,096	24,288	27,451	18,692	14,711	16,448	20,132	22,614	23,192	15,895	6,691	15,391	817	724	-	337	-
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Cash And Short Term Investments	105,074	82,691	69,959	26,978	32,680	47,986	41,660	24,288	27,451	18,692	14,711	16,448	20,132	22,614	24,000	21,254	22,889	30,808	817	1,024	-	337	-
Common Stock	239	237	235	221	217	211	207	200	197	188	170	165	163	161	159	157	155	153	86	81	-	-	-
Common Stock Shares Outstanding	22,423	22,171	21,475	20,479	20,326	20,242	20,033	19,241	18,316	17,008	15,764	15,638	15,989	16,114	15,916	15,572	15,398	9,904	8,701	8,354	7,650	7,693	7,160
Common Stock Total Equity	0	237	235	221	217	211	207	200	197	188	170	165	163	161	159	157	155	153	86	81	-	-	-
Current Deferred Revenue	390	0	16,332	17,525	14,021	552	0	0	0	0	0	0	0	0	0	0	6,661	0	0	2,592	-	-	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	1,378	1,399	1,205	1,418	1,615	273	6	0	0	0	0	0	0	0	-	-	-
Deferred Long Term Liab	0	0	70	700	1,179	0	2,176	1,941	1,678	2,919	3,461	1,673	989	0	0	0	0	0	0	0	-	-	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Good Will	65,945	65,945	65,945	65,945	41,656	29,868	23,844	23,426	17,789	17,281	15,031	13,749	11,917	11,917	11,022	11,022	10,942	8,853	8,853	6,709	-	-	-
Intangible Assets	41,711	46,527	52,710	58,905	23,188	13,692	8,234	9,897	6,336	7,157	6,144	5,191	2,985	3,686	3,316	2,883	3,886	1,930	2,412	1,626	-	-	-
Inventory	52,333	50,271	46,104	45,115	39,526	27,388	21,046	19,578	15,205	16,714	13,255	10,859	8,003	8,375	6,498	6,959	9,589	6,081	5,147	3,272	-	-	-
Liabilities And Stockholders Equity	346,778	310,476	292,802	252,810	188,339	153,088	126,323	101,924	90,704	81,492	70,492	63,060	59,687	63,274	56,906	54,399	61,151	56,963	25,068	20,501	-	12,718	12,162
Long Term Debt	0	0	0	35,532	0	0	0	0	0	0	0	0	0	0	188	78	42	0	677	1,140	-	-	-
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Debt	-5,174	-2,538	2,082	28,013	3,926	-26,318	-19,096	-24,288	-27,451	-18,692	-14,711	-16,448	-20,132	-22,614	-23,004	-15,817	-6,387	-15,359	1,092	888	-	595	670
Net Invested Capital	297,900	268,201	254,151	210,604	148,141	130,235	109,770	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Receivables	25,064	22,040	19,631	19,552	16,572	15,721	15,000	13,191	11,971	10,803	10,590	9,048	8,541	8,475	7,778	7,244	7,020	5,060	4,207	3,745	-	-	-
Net Tangible Assets	0	155,729	135,496	113,667	108,190	86,675	77,692	54,177	53,759	43,769	35,387	33,948	37,186	0	0	0	0	0	0	0	-	-	-
Net Working Capital	164,719	136,404	118,070	69,118	71,241	74,259	67,122	48,545	47,816	38,547	31,505	30,957	33,148	32,522	33,002	30,183	31,721	38,263	5,722	5,296	-	-	-
Non Current Assets Total	157,927	148,743	152,919	158,547	96,249	59,071	46,012	42,897	32,520	32,904	28,767	23,709	20,000	20,363	17,356	17,283	19,091	13,322	14,251	11,399	-	6,782	6,296
Non Current Liabilities Other	1,631	14,710	2,701	4,643	18,170	1,522	1,188	2,001	774	325	249	105	71	0	0	0	0	0	0	0	-	-	-
Non Current Liabilities Total	18,999	16,946	16,838	55,093	19,338	3,095	3,364	3,942	2,452	3,244	3,710	1,778	1,060	529	2,145	1,718	2,226	886	1,437	1,882	-	2,332	-
Non Currrent Assets Other	9,487	991	568	909	259	194	178	163	168	170	167	172	431	820	917	1,051	1,372	150	328	629	-	6,782	6,296
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Assets	0	2,736	2,134	18,447	1,343	1,409	1,556	1,562	1,373	1,588	1,782	445	437	954	917	1,051	1,372	150	328	629	-	-	-
Other Current Assets	6,380	6,731	4,189	2,618	3,312	4,739	4,428	4,587	3,557	2,379	3,169	2,996	3,011	3,447	1,274	1,659	2,562	1,692	646	429	-	5,599	5,866
Other Current Liab	23,284	20,540	1,271	772	2,476	14,547	11,646	9,265	9,002	8,914	8,985	7,334	5,558	9,069	5,412	6,327	851	4,528	3,598	276	-	1,430	-670
Other Liab	0	2,236	2,771	4,770	5,394	3,095	3,364	3,942	2,452	325	249	105	71	86	411	380	1,188	53	156	344	-	-	-
Other Stockholder Equity	186,856	176,222	169,226	103,322	94,902	88,093	83,519	76,548	73,575	67,136	57,312	57,025	58,971	61,207	62,556	62,057	61,020	60,419	18,415	13,809	-	8,024	1,710
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,191	2,191	-	-	-
Property Plant And Equipment Gross	61,269	33,535	17,059	31,102	30,062	14,102	12,378	8,012	7,022	6,878	5,810	4,544	4,661	3,806	2,101	2,327	2,891	2,389	2,658	2,435	-	-	-
Property Plant And Equipment Net	39,781	33,535	32,130	31,102	30,062	14,102	12,378	8,012	7,022	6,878	5,810	4,544	4,661	3,806	2,101	2,327	2,891	2,389	2,658	2,435	-	-	-
Property Plant Equipment	0	17,901	32,130	15,036	14,854	14,102	12,378	8,012	7,022	6,878	5,810	4,544	4,661	3,806	2,101	2,327	2,891	2,389	2,658	2,435	-	-	-
Retained Earnings	115,430	97,773	88,125	70,554	57,031	45,831	28,333	15,335	8,161	3,248	-667	-3,869	-6,440	-8,583	-14,596	-16,194	-12,880	-9,946	-2,005	-2,060	-	-	-
Retained Earnings Total Equity	0	97,773	88,125	70,554	57,029	45,831	28,333	15,335	8,161	3,248	-667	-3,869	-6,440	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt	0	0	0	2,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Short Long Term Debt Total	19,095	16,596	15,937	54,777	15,712	0	0	0	0	0	0	0	0	0	188	78	304	32	1,909	1,612	-	932	670
Short Term Debt	2,471	1,886	1,870	4,454	1,757	2,927	0	0	0	0	0	0	0	0	0	0	262	32	1,232	472	-	932	670
Short Term Investments	80,805	63,557	56,104	214	20,894	21,668	22,564	0	0	0	0	0	0	0	808	5,359	16,198	15,417	0	300	-	-	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Assets	346,778	310,476	292,802	252,810	188,339	153,088	126,323	101,924	90,704	81,492	70,492	63,060	59,687	63,274	56,906	54,399	61,151	56,963	25,068	20,501	-	12,718	12,162
Total Current Assets	188,851	161,733	139,883	94,263	92,090	94,017	80,311	59,027	58,184	48,588	41,725	39,351	39,687	42,911	39,550	37,116	42,060	43,641	10,817	9,102	-	5,936	5,866
Total Current Liabilities	29,879	25,329	21,813	25,145	20,858	19,758	13,189	10,482	10,368	10,041	10,220	8,394	6,539	10,389	6,548	6,933	10,339	5,378	5,095	3,806	-	2,362	670
Total Liab	48,878	42,275	38,651	80,238	40,196	22,853	16,553	14,424	12,820	13,285	13,930	10,172	7,599	10,918	8,693	8,651	12,565	6,264	6,532	5,688	-	4,694	5,044
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Stockholder Equity	297,900	268,201	254,151	172,572	148,143	130,235	109,770	87,500	77,884	68,207	56,562	52,888	52,088	52,356	48,213	45,748	48,586	50,699	18,536	14,813	-	8,024	1,710
Treasury Stock	0	-13,046	-12,404	-11,602	-11,032	-10,349	-9,608	-8,830	-8,519	-8,253	-8,042	-7,669	-5,648	-3,435	-919	-233	-167	-85	-783	-222	-	-	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31
Accounts Payable	3,734	4,371	3,519	3,371	2,903	2,848	2,844	2,194	2,340	3,137	2,059	2,561	2,394	2,168	1,237	1,381	2,604	1,670	1,427	2,381	1,732	1,627	1,657	1,440	1,543	1,617	1,574	2,220	1,217	1,148	1,550	1,773	1,366	931	1,293	1,128	1,127	1,021	1,021	1,040	1,235	748	1,011	929	1,060	879	937	825	981	1,276	1,199	1,726	1,320	1,425	1,072	1,483	1,136	1,043	1,233	1,052	606	814	2,108	2,536	2,565	1,349	1,311	1,181	818	629	828	726	265	-	0	0	466	0	0	0
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-4,625	-6,705	-5,822	-5,572	-6,031	-8,127	-6,444	-4,624	-3,435	-2,636	-2,243	-2,463	-1,525	-3,009	-4,159	-5,525	-4,007	-4,894	-3,818	-4,092	-3,900	-3,482	-3,207	-2,006	-2,289	-2,280	-2,944	-3,963	-4,583	-3,213	-3,525	-3,120	-4,049	-4,033	-3,525	-3,961	-2,365	-1,628	-250	-226	-253	-343	-653	-728	-433	-500	-618	-313	-606	-460	-6	-132	-429	-361	-1,217	-457	94	420	126	-381	-272	-255	371	698	291	123	68	139	73	38	-32	-127	-151	-	0	0	792	0	0	0
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Capital Lease Obligations	19,095	16,881	16,807	16,505	16,596	16,725	17,214	15,577	15,937	16,490	17,023	16,208	16,745	16,998	17,314	15,418	15,712	6,421	6,850	6,701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Capital Stock	239	239	239	238	237	236	235	235	235	234	222	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Capital Surpluse	0	0	196,941	192,003	189,268	186,798	184,605	183,305	181,630	179,070	119,291	117,236	114,924	109,640	107,791	106,946	105,934	103,673	100,890	99,666	98,442	97,727	95,122	94,040	93,127	92,685	88,759	86,683	85,378	84,837	83,425	82,563	82,094	80,188	77,053	76,041	75,389	75,480	75,497	65,209	65,354	64,983	64,524	64,683	64,694	64,442	64,416	64,500	64,619	64,622	64,605	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Cash	24,269	18,051	19,488	16,677	19,134	16,913	20,788	15,560	13,855	17,369	21,541	23,525	26,764	29,279	19,976	10,944	11,786	11,719	13,264	14,766	26,318	20,104	19,638	22,781	19,096	37,514	30,120	25,810	24,288	34,650	29,315	25,941	27,451	23,629	19,430	17,025	18,692	18,354	23,512	12,504	14,711	13,626	14,910	15,302	16,448	20,639	20,162	19,622	20,132	23,087	21,405	19,103	22,614	27,453	25,608	23,662	23,192	19,809	16,740	14,093	15,895	13,163	10,648	5,444	6,691	7,752	12,474	13,241	15,391	453	666	469	817	-	0	0	724	0	0	0
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Cash And Short Term Investments	105,074	97,018	90,177	81,005	82,691	79,739	75,683	70,882	69,959	67,079	21,756	23,739	26,978	34,376	25,050	30,631	32,680	44,896	48,243	47,457	47,986	45,627	52,936	45,394	41,660	37,514	30,120	25,810	24,288	34,650	29,315	25,941	27,451	23,629	19,430	17,025	18,692	18,354	23,512	12,504	14,711	13,626	14,910	15,302	16,448	20,639	20,162	19,622	20,132	23,087	21,405	19,103	22,614	27,622	25,950	24,098	24,000	22,725	19,818	17,264	21,254	19,163	18,271	17,802	22,889	25,637	27,933	28,620	30,808	453	666	469	817	-	0	0	1,024	0	0	0
Common Stock	239	239	239	238	237	236	235	235	235	234	222	221	221	218	217	217	217	215	213	212	211	211	208	208	207	207	204	202	200	200	199	198	197	195	191	189	188	188	187	170	170	168	166	166	165	164	163	163	163	163	162	161	161	161	159	159	159	158	157	157	157	157	156	155	155	155	155	154	153	85	86	86	86	-	0	0	81	0	0	0
Common Stock Shares Outstanding	22,459	22,481	22,451	22,274	22,238	22,217	22,129	22,103	22,138	21,935	20,959	20,847	20,621	20,474	20,399	20,438	20,484	20,378	20,246	20,205	20,179	20,293	20,260	20,181	20,191	20,147	19,975	19,707	19,558	19,248	18,978	18,860	18,781	18,497	18,065	17,796	17,713	17,709	16,545	15,586	15,921	15,780	15,701	15,648	15,597	15,605	15,636	15,726	15,294	16,030	16,071	16,038	15,465	16,157	16,050	16,036	15,678	15,934	15,866	15,661	15,661	15,608	15,542	15,506	15,506	15,410	15,760	15,338	8,497	8,497	8,539	10,317	5,600	5,600	8,497	8,497	8,497	8,497	8,497	8,497
Common Stock Total Equity	0	0	239	238	237	236	235	235	235	234	222	221	221	218	217	217	217	215	213	212	211	211	208	208	207	207	204	202	200	200	199	198	197	195	191	189	188	188	187	170	170	168	166	166	165	164	163	163	163	163	162	161	161	161	159	159	159	158	157	157	157	157	156	155	155	155	155	154	153	85	86	86	86	-	0	0	81	0	0	0
Current Deferred Revenue	390	21,788	19,327	0	0	0	0	0	16,332	16,460	13,766	14,365	17,525	14,679	11,836	11,015	14,021	13,390	188	368	552	752	951	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6,661	0	0	0	0	0	0	0	0	-	0	0	2,592	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,164	0	0	0	1,336	1,347	1,419	1,378	1,562	1,514	1,421	1,399	1,327	1,245	1,265	1,205	1,306	1,309	1,263	1,418	1,620	1,610	1,619	1,615	258	259	262	273	6	6	7	6	136	147	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Deferred Long Term Liab	0	0	72	71	0	0	0	68	70	122	700	700	700	700	0	1,176	1,179	0	484	484	0	2,174	2,175	2,177	2,176	1,948	1,946	1,941	1,941	1,680	1,679	1,680	1,678	2,917	2,918	2,917	2,919	3,400	3,476	3,475	3,461	1,673	1,673	1,673	1,673	989	989	989	989	443	443	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Good Will	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	65,945	66,151	39,773	41,656	32,102	29,860	29,880	29,868	31,544	23,602	23,810	23,844	23,850	23,645	23,629	23,426	18,206	18,150	18,192	17,789	17,717	17,900	17,132	17,281	17,441	15,031	15,031	15,031	15,031	13,749	13,749	13,749	11,917	11,917	11,917	11,917	11,917	11,917	11,917	11,917	11,022	11,022	11,022	11,022	11,022	11,022	11,022	11,022	10,922	10,959	10,959	10,942	11,096	9,161	8,853	8,853	8,853	8,853	8,853	8,853	-	0	0	6,709	0	0	0
Intangible Assets	41,711	43,199	43,999	45,508	46,527	48,063	49,598	51,194	52,710	54,230	55,777	57,339	58,905	60,539	63,165	24,059	23,188	16,765	12,632	13,179	13,692	12,248	7,358	7,806	8,234	8,669	9,083	9,524	9,897	5,872	6,211	6,660	6,336	6,656	6,941	6,619	7,157	7,635	5,250	5,758	6,144	6,127	4,840	4,965	5,191	2,415	2,568	2,800	2,985	3,243	3,535	3,458	3,686	2,737	2,768	3,105	3,316	3,502	3,631	3,717	2,883	3,088	3,349	3,507	3,886	2,302	1,864	1,861	1,930	1,937	1,980	2,328	2,412	-	0	0	1,626	0	0	0
Inventory	52,333	56,187	53,831	53,779	50,271	47,711	47,192	46,664	46,104	44,326	44,751	45,071	45,115	45,639	46,340	40,580	39,526	36,695	32,243	29,408	27,388	23,876	21,669	21,833	21,046	21,095	20,463	20,596	19,578	17,430	16,961	17,897	15,205	15,920	15,781	16,456	16,714	16,925	14,995	14,186	13,255	13,082	11,654	11,265	10,859	10,130	9,127	8,297	8,003	7,250	7,811	9,118	8,375	6,910	6,140	6,252	6,498	6,495	7,000	7,165	6,959	8,103	9,658	10,266	9,589	8,146	7,335	7,109	6,081	6,011	5,675	5,392	5,147	-	0	0	3,272	0	0	0
Liabilities And Stockholders Equity	346,778	334,012	326,467	314,866	310,476	302,048	299,425	292,453	292,802	289,473	246,505	247,369	252,810	261,569	255,717	184,557	188,339	170,014	162,661	160,252	153,088	144,327	137,100	129,410	126,323	121,269	112,054	106,522	101,924	101,306	95,529	93,384	90,704	86,612	83,237	79,573	81,492	83,405	80,536	68,718	70,492	66,596	63,675	63,246	63,060	61,192	59,999	59,389	59,687	63,024	61,691	61,052	63,274	61,438	58,049	56,951	56,906	56,319	53,703	50,890	54,399	53,571	56,028	56,785	61,151	57,095	56,228	55,964	56,963	27,649	27,681	26,461	25,068	-	0	0	20,501	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0	19,448	28,485	35,532	36,229	36,990	0	0	0	5,152	5,263	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	156	137	149	188	187	68	79	78	40	45	45	42	0	0	0	0	2,824	0	0	677	-	0	0	1,140	0	0	0
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	19,448	0	0	0	36,990	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Net Debt	-5,174	-1,170	-2,681	-172	-2,538	-188	-3,574	17	2,082	-879	17,930	23,918	28,013	47,198	61,328	4,474	3,926	-5,298	-6,414	-8,065	-26,318	-20,104	-19,638	-22,781	-19,096	-37,514	-30,120	-25,810	-24,288	-34,650	-29,315	-25,941	-27,451	-23,629	-19,430	-17,025	-18,692	-18,354	-23,512	-12,504	-14,711	-13,626	-14,910	-15,302	-16,448	-20,639	-20,162	-19,622	-20,132	-23,087	-21,405	-19,103	-22,614	-27,297	-25,471	-23,513	-23,004	-19,622	-16,672	-14,014	-15,817	-13,123	-10,603	-5,399	-6,387	-7,752	-12,474	-13,235	-15,359	3,929	2,946	1,684	1,092	-	0	0	888	0	0	0
Net Invested Capital	297,900	288,637	283,827	274,165	268,201	261,247	258,033	257,787	254,151	249,048	208,281	208,760	210,604	220,462	216,619	148,835	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Net Receivables	25,064	23,882	26,406	25,365	22,040	20,094	21,542	21,386	19,631	19,501	20,741	20,126	19,552	19,625	17,696	16,630	16,572	14,878	15,548	15,460	15,721	13,015	15,230	14,510	15,000	13,553	14,590	14,090	13,191	12,176	12,838	13,017	11,971	11,339	12,242	11,877	10,803	10,590	11,373	10,494	10,590	9,273	9,714	9,357	9,048	8,474	8,801	8,690	8,541	8,853	9,066	9,371	8,475	8,166	7,861	8,054	7,778	7,838	7,767	7,164	7,244	6,788	7,148	7,166	7,020	6,221	6,080	5,687	5,060	4,808	4,925	4,826	4,207	-	0	0	3,745	0	0	0
Net Tangible Assets	0	0	283,827	274,165	155,729	147,239	142,490	140,648	135,496	128,873	64,111	177,525	113,667	160,983	152,629	148,835	108,190	142,316	137,537	133,088	86,675	82,053	89,784	81,854	77,692	73,594	65,583	58,465	54,177	62,612	58,489	55,772	53,759	49,813	45,598	44,176	43,769	42,043	47,502	35,447	35,387	34,234	35,542	34,624	33,948	37,574	37,488	37,329	37,186	37,485	37,352	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Net Working Capital	164,719	153,155	148,635	140,864	136,404	129,703	125,081	123,144	118,070	111,902	68,540	68,357	69,118	57,806	47,512	73,128	71,232	80,372	80,737	76,033	74,259	71,057	79,249	71,366	67,122	63,532	58,692	51,739	48,545	56,171	52,286	49,578	47,816	45,144	41,070	39,409	38,547	36,948	43,990	31,626	31,505	29,810	31,379	30,854	30,957	33,996	33,732	33,332	33,148	33,031	33,254	32,853	32,522	36,344	34,492	33,606	33,002	31,698	29,774	27,921	30,183	29,476	29,039	29,584	31,721	34,360	37,819	37,823	38,263	6,213	3,368	5,101	5,722	-	0	0	5,296	0	0	0
Non Current Assets Total	157,927	151,828	151,977	150,098	148,743	148,906	150,939	151,042	152,919	155,457	156,485	156,712	158,547	159,317	163,848	94,835	96,249	70,319	64,502	64,834	59,071	57,516	44,736	45,402	46,012	45,627	43,965	44,018	42,897	33,071	33,107	33,642	32,520	32,635	32,928	31,776	32,904	33,971	27,534	28,383	28,767	27,558	24,840	24,518	23,709	19,001	19,331	19,771	20,000	20,132	20,075	19,982	20,363	17,282	16,855	17,113	17,356	17,726	17,717	17,848	17,283	17,611	18,504	18,874	19,091	15,995	13,536	13,233	13,322	15,576	15,684	15,035	14,251	-	0	0	11,399	0	0	0
Non Current Liabilities Other	1,631	2,145	2,264	2,278	14,710	2,405	2,503	2,626	2,701	18,189	4,550	4,575	4,643	3,901	4,306	4,237	18,170	4,755	7,218	7,295	0	2,167	1,066	1,121	1,188	1,098	2,400	2,198	2,001	872	864	916	774	676	641	341	325	400	265	298	249	243	415	361	105	102	101	68	71	75	82	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Non Current Liabilities Total	18,999	16,346	16,785	16,797	16,946	17,362	17,987	16,399	16,838	18,311	39,192	47,544	55,093	56,140	58,731	19,128	19,338	8,375	7,702	7,779	3,095	3,226	3,241	3,298	3,364	3,046	4,346	4,139	3,942	2,552	2,543	2,596	2,452	3,593	3,559	3,258	3,244	3,800	3,741	3,773	3,710	1,916	2,088	2,034	1,778	1,091	1,090	1,057	1,060	518	525	525	529	2,326	2,170	2,141	2,145	2,071	1,850	1,774	1,718	1,860	1,852	1,771	2,226	850	859	866	886	10,330	7,869	1,277	1,437	-	0	0	1,882	0	0	0
Non Currrent Assets Other	-32,224	3,152	2,931	2,074	991	973	984	556	568	994	1,076	1,110	909	942	1,027	260	259	210	210	210	194	191	194	197	178	179	179	165	163	176	177	170	168	168	168	168	170	174	169	168	167	158	156	163	172	173	233	416	431	442	596	348	820	878	832	842	917	971	966	966	1,051	1,077	1,376	1,433	1,372	162	159	163	150	2,280	2,132	1,098	328	-	0	0	629	0	0	0
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Other Assets	0	0	0	3,876	2,736	3,762	3,353	2,533	2,134	2,621	2,725	2,750	18,447	2,327	2,113	1,329	1,343	1,374	1,419	1,400	1,409	1,528	1,541	1,616	33,634	34,260	34,421	34,739	34,885	25,581	25,783	26,287	25,498	25,847	26,318	25,182	26,026	26,870	22,060	22,576	22,957	21,574	19,004	19,139	19,385	14,511	14,724	15,140	15,339	15,738	16,048	15,867	16,557	14,637	14,622	14,969	15,255	15,495	15,619	15,705	14,956	15,087	15,684	15,899	16,200	13,560	11,184	10,877	10,933	13,070	0	0	11,593	-	0	0	8,964	0	0	0
Other Current Assets	6,380	5,097	4,076	4,619	6,731	10,875	9,501	7,795	4,189	8,638	8,373	7,555	8,568	8,730	8,651	7,089	8,210	7,637	-1	5,097	4,739	5,718	3,728	3,607	4,428	5,483	5,254	4,716	4,587	3,979	3,308	2,887	3,557	3,089	2,856	2,439	2,379	3,565	3,122	3,151	3,169	3,057	2,557	2,804	2,996	2,948	2,578	3,009	3,011	3,702	3,187	3,478	3,447	1,458	1,243	1,434	1,274	1,535	1,401	1,449	1,659	1,906	2,447	2,677	2,562	1,096	1,344	1,315	1,692	801	731	739	646	-	0	0	429	0	0	0
Other Current Liab	23,284	121	651	18,476	20,540	18,763	18,767	14,201	1,271	616	701	776	772	2,543	2,517	2,495	2,476	2,597	14,109	15,198	2,179	3,121	172	11,202	11,646	10,493	7,823	8,545	9,265	10,916	8,586	8,391	9,002	7,902	7,946	7,260	8,914	11,465	7,991	7,669	8,985	8,480	6,445	6,945	7,334	7,316	5,999	5,461	5,558	8,585	7,163	6,491	9,069	6,387	5,630	4,749	5,412	5,852	4,979	4,069	6,327	5,670	6,377	5,791	851	5,391	3,562	3,721	4,528	3,673	4,621	3,992	3,598	-	0	0	276	0	0	0
Other Liab	0	0	0	2,349	2,236	2,465	2,567	2,694	2,771	3,722	4,675	4,699	4,770	4,719	6,194	5,413	5,394	3,620	2,550	2,516	3,095	4,341	3,241	3,298	1,188	1,098	2,400	2,198	2,001	872	864	916	774	676	641	341	325	400	265	298	249	243	415	361	105	102	101	68	71	75	82	82	86	391	347	376	411	413	381	364	380	438	456	514	1,188	17	26	33	53	133	0	0	156	-	0	0	344	0	0	0
Other Stockholder Equity	186,856	185,022	183,714	178,785	176,222	174,242	172,052	170,756	169,226	167,094	107,601	105,546	103,322	98,317	96,702	95,857	94,902	92,878	90,518	89,296	88,093	87,440	85,509	84,432	83,519	83,077	79,929	77,853	76,548	76,135	74,904	74,044	73,575	71,668	68,794	67,782	67,136	67,227	67,448	57,166	57,312	56,980	56,752	56,924	57,025	56,809	57,658	58,250	58,971	59,728	60,648	61,110	61,207	62,047	62,299	62,451	62,556	62,640	62,510	62,294	62,057	61,831	61,533	61,279	61,020	60,929	60,621	60,472	60,419	18,417	18,352	18,344	18,415	-	0	0	13,809	0	0	0
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8,960	0	0	2,191	-	0	0	2,191	0	0	0
Property Plant And Equipment Gross	61,269	37,207	37,021	34,769	33,535	31,136	0	0	17,059	0	32,038	30,678	31,102	30,505	32,419	29,674	30,062	20,078	20,591	20,375	14,102	12,695	12,235	12,170	12,378	11,367	9,544	9,279	8,012	7,490	7,324	7,355	7,022	6,788	6,610	6,594	6,878	7,196	5,474	5,807	5,810	5,984	5,836	5,379	4,544	4,490	4,607	4,631	4,661	4,394	4,027	4,115	3,806	2,645	2,233	2,144	2,101	2,231	2,098	2,143	2,327	2,524	2,820	2,975	2,891	2,435	2,352	2,356	2,389	2,506	2,719	2,756	2,658	-	0	0	2,435	0	0	0
Property Plant And Equipment Net	39,781	37,207	37,021	34,769	33,535	31,136	32,043	31,370	32,130	32,661	32,038	30,678	31,102	30,506	32,419	29,674	30,062	20,078	20,591	20,375	14,102	12,197	12,235	12,170	12,378	11,367	9,544	9,279	8,012	7,490	7,324	7,355	7,022	6,788	6,610	6,594	6,878	7,196	5,474	5,807	5,810	5,984	5,836	5,379	4,544	4,490	4,607	4,631	4,661	4,394	4,027	4,115	3,806	2,645	2,233	2,144	2,101	2,231	2,098	2,143	2,327	2,524	2,820	2,975	2,891	2,435	2,352	2,356	2,389	2,506	2,719	2,756	2,658	-	0	0	2,435	0	0	0
Property Plant Equipment	0	0	21,217	19,242	17,901	31,136	32,043	31,370	32,130	16,997	32,038	15,200	15,036	14,133	15,685	14,791	14,854	14,070	14,163	14,109	14,102	12,695	12,235	12,170	12,378	11,367	9,544	9,279	8,012	7,490	7,324	7,355	7,022	6,788	6,610	6,594	6,878	7,196	5,474	5,807	5,810	5,984	5,836	5,379	4,544	4,490	4,607	4,631	4,661	4,394	4,027	4,115	3,806	2,645	2,233	2,144	2,101	2,231	2,098	2,143	2,327	2,524	2,820	2,975	2,891	2,435	2,352	2,356	2,389	2,506	0	0	2,658	-	0	0	2,435	0	0	0
Retained Earnings	115,430	110,081	105,696	100,714	97,773	94,896	92,190	91,420	88,125	84,356	80,253	74,221	70,554	65,457	59,869	58,286	57,031	54,117	50,624	47,672	45,831	41,178	38,234	30,836	28,333	25,109	21,122	17,526	15,335	13,568	11,272	9,502	8,161	6,356	4,979	3,917	3,248	1,332	398	-874	-667	-1,353	-2,134	-3,024	-3,869	-4,567	-5,230	-6,054	-6,440	-6,786	-8,000	-8,829	-8,583	-10,547	-12,064	-13,575	-14,596	-15,865	-17,152	-18,075	-16,194	-16,506	-16,369	-15,445	-12,880	-11,702	-10,348	-10,575	-9,946	-9,272	-9,414	-1,635	-2,005	-	0	0	-2,060	0	0	0
Retained Earnings Total Equity	0	0	105,696	100,714	97,773	94,896	92,190	91,420	88,125	84,356	80,253	74,221	70,554	65,457	59,869	58,286	57,029	54,117	50,624	47,672	45,831	41,178	38,234	30,836	28,333	25,109	21,122	17,526	15,335	13,568	11,272	9,502	8,161	6,356	4,979	3,917	3,248	1,332	398	-874	-667	-1,413	-2,134	-3,024	-3,869	-4,567	-5,230	-6,054	-6,440	-6,786	-8,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Short Long Term Debt	0	0	0	0	0	0	0	0	0	0	3,000	2,750	2,500	23,250	27,000	0	0	0	1,698	1,438	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Short Long Term Debt Total	19,095	16,881	16,807	16,505	16,596	16,725	17,214	15,577	15,937	16,490	39,471	47,443	54,777	76,477	81,304	15,418	15,712	6,421	6,850	6,701	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	156	137	149	188	187	68	79	78	40	45	45	304	0	0	6	32	4,382	3,612	2,153	1,909	-	0	0	1,612	0	0	0
Short Term Debt	2,471	2,749	2,358	2,057	1,886	1,828	1,794	1,872	1,870	1,901	4,954	4,598	4,454	25,056	28,767	1,703	1,757	1,666	1,698	1,438	15,295	10,254	10,335	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	262	262	0	0	6	32	1,558	3,180	1,607	1,232	-	0	0	472	0	0	0
Short Term Investments	80,805	78,967	70,689	64,328	63,557	62,826	54,895	55,322	56,104	49,710	215	214	214	5,097	5,074	19,687	20,894	33,177	34,979	32,691	21,668	25,523	33,298	22,613	22,564	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	169	342	436	808	2,916	3,078	3,171	5,359	6,000	7,623	12,358	16,198	17,885	15,459	15,379	15,417	0	0	0	0	-	0	0	300	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Total Assets	346,778	334,012	326,467	314,866	310,476	302,048	299,425	292,453	292,802	289,473	246,505	247,369	252,810	261,569	255,717	184,557	188,339	170,014	162,661	160,252	153,088	144,327	137,100	129,410	126,323	121,269	112,054	106,522	101,924	101,306	95,529	93,384	90,704	86,612	83,237	79,573	81,492	83,405	80,536	68,718	70,492	66,596	63,675	63,246	63,060	61,192	59,999	59,389	59,687	63,024	61,691	61,052	63,274	61,438	58,049	56,951	56,906	56,319	53,703	50,890	54,399	53,571	56,028	56,785	61,151	57,095	56,228	55,964	56,963	27,649	27,681	26,461	25,068	-	0	0	20,501	0	0	0
Total Current Assets	188,851	182,184	174,490	164,768	161,733	153,142	148,486	141,411	139,883	134,016	90,020	90,657	94,263	102,252	91,869	89,722	92,090	99,695	98,159	95,418	94,017	86,811	92,364	84,008	80,311	75,642	68,089	62,504	59,027	68,235	62,422	59,742	58,184	53,977	50,309	47,797	48,588	49,434	53,002	40,335	41,725	39,038	38,835	38,728	39,351	42,191	40,668	39,618	39,687	42,892	41,616	41,070	42,911	44,156	41,194	39,838	39,550	38,593	35,986	33,042	37,116	35,960	37,524	37,911	42,060	41,100	42,692	42,731	43,641	12,073	11,997	11,426	10,817	-	0	0	9,102	0	0	0
Total Current Liabilities	29,879	29,029	25,855	23,904	25,329	23,439	23,405	18,267	21,813	22,114	21,480	22,300	25,145	44,446	44,357	16,594	20,858	19,323	17,422	19,385	19,758	15,754	13,115	12,642	13,189	12,110	9,397	10,765	10,482	12,064	10,136	10,164	10,368	8,833	9,239	8,388	10,041	12,486	9,012	8,709	10,220	9,228	7,456	7,874	8,394	8,195	6,936	6,286	6,539	9,861	8,362	8,217	10,389	7,812	6,702	6,232	6,548	6,895	6,212	5,121	6,933	6,484	8,485	8,327	10,339	6,740	4,873	4,908	5,378	5,860	8,629	6,325	5,095	-	0	0	3,806	0	0	0
Total Liab	48,878	45,375	42,640	40,701	42,275	40,801	41,392	34,666	38,651	40,425	60,672	69,844	80,238	100,586	103,088	35,722	40,196	27,698	25,124	27,164	22,853	18,980	16,356	15,940	16,553	15,156	13,743	14,904	14,424	14,616	12,679	12,760	12,820	12,426	12,798	11,646	13,285	16,286	12,753	12,482	13,930	11,144	9,544	9,908	10,172	9,286	8,026	7,343	7,599	10,379	8,887	8,742	10,918	10,138	8,872	8,373	8,693	8,966	8,062	6,895	8,651	8,344	10,337	10,098	12,565	7,590	5,732	5,774	6,264	16,190	16,498	7,602	6,532	-	0	0	5,688	0	0	0
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Total Stockholder Equity	297,900	288,637	283,827	274,165	268,201	261,247	258,033	257,787	254,151	249,048	185,833	177,525	172,572	160,983	152,629	148,835	148,143	142,316	137,537	133,088	130,235	125,347	120,744	113,470	109,770	106,113	98,311	91,618	87,500	86,690	82,850	80,624	77,884	74,186	70,439	67,927	68,207	67,119	67,783	56,236	56,562	55,452	54,131	53,338	52,888	51,906	51,973	52,046	52,088	52,645	52,804	52,310	52,356	51,300	49,177	48,578	48,213	47,353	45,641	43,995	45,748	45,227	45,691	46,687	48,586	49,505	50,496	50,190	50,699	11,459	11,183	18,859	18,536	-	0	0	14,813	0	0	0
Treasury Stock	0	0	0	0	-13,046	-12,556	-12,553	-12,549	-12,404	-11,976	-11,690	-11,690	-11,602	-11,323	-11,089	-11,089	-11,032	-10,795	-10,372	-10,370	-10,349	-10,287	-9,613	-9,608	-9,608	-9,608	-8,830	-8,830	-8,830	-8,702	-8,521	-8,519	-8,519	-8,520	-8,259	-8,259	-8,253	-8,253	-8,049	-8,043	-8,042	-8,003	-7,772	-7,759	-7,669	-7,633	-6,758	-6,250	-5,648	-4,894	-3,957	-3,811	-3,435	-2,234	-1,639	-1,239	-919	-413	-245	-235	-233	-204	-184	-175	-167	-85	-85	-85	-85	0	0	0	-783	-	0	0	-222	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31
Begin Period Cash Flow	19,134	13,855	26,764	11,786	26,318	19,096	24,288	27,451	18,692	14,711	16,448	20,132	22,614	23,192	15,895	6,397	17,626	817	724	559
Capital Expenditures	7,265	3,229	4,882	2,982	3,761	3,054	6,417	2,843	2,290	1,189	2,897	1,325	2,085	2,558	1,625	738	1,393	969	1,013	1,563
Cash And Cash Equivalents Changes	0	5,773	-12,272	14,064	-14,532	7,222	-5,192	-3,163	8,759	3,981	-1,737	-3,684	-2,482	0	0	0	0	0	0	0
Cash Flows Other Operating	0	-10,514	-7,412	-2,520	-11,989	-4,680	-1,410	1,394	-2,035	691	-179	55	105	0	0	0	0	0	0	0
Change In Cash	5,135	5,279	-12,909	14,978	-14,532	7,222	-5,192	-3,163	8,759	3,981	-1,737	-3,684	-2,482	-578	7,297	9,498	-10,935	14,574	93	165
Change In Working Capital	-11,254	-13,402	-9,964	863	-13,886	-1,649	-1,623	369	-689	-3,898	-2,790	-2,705	-4,237	-427	445	-525	-1,979	-1,220	-2,141	-700
Change Receivables	0	-3,533	-818	-939	-1,301	-1,283	-1,507	-922	-1,879	-654	-1,247	-640	-174	0	0	0	0	0	0	0
Change To Account Receivables	-3,135	-3,533	-818	-939	-1,301	-1,283	-1,507	-922	-1,879	-654	-1,247	-640	-174	-973	-486	-353	197	-689	0	0
Change To Inventory	-9,794	-7,418	-5,485	-2,609	-11,335	-4,262	-1,352	-134	608	-2,711	-2,168	-3,725	-998	-1,735	164	1,473	-1,800	-780	-1,769	167
Change To Liabilities	0	645	-1,734	4,322	-596	4,314	1,524	-103	2,617	-1,086	861	1,357	-3,170	0	0	0	0	0	0	0
Change To Netincome	0	8,711	7,089	4,322	4,715	-6,112	3,029	2,346	975	2,023	2,126	2,870	3,227	0	0	0	0	0	0	0
Change To Operating Activities	0	-3,096	-1,927	89	-654	-418	-288	1,528	-2,035	553	0	0	0	0	0	0	0	0	0	0
Depreciation	9,515	9,433	11,070	8,395	5,416	4,324	4,055	3,591	3,394	3,334	2,793	2,234	2,037	1,376	1,419	1,593	1,394	1,308	1,208	967
Dividends Paid	12,448	10,988	9,336	7,695	6,736	5,445	4,179	3,323	2,845	2,308	1,838	1,518	1,237	0	0	328	0	0	0	0
End Period Cash Flow	24,269	19,134	13,855	26,764	11,786	26,318	19,096	24,288	27,451	18,692	14,711	16,448	20,132	22,614	23,192	15,895	6,691	15,391	817	724
Exchange Rate Changes	0	0	0	0	11	-813	818	-271	-278	-445	24	-51	-30	0	0	0	0	0	0	0
Free Cash Flow	29,486	22,149	30,220	31,818	10,418	16,452	16,451	14,053	9,148	4,323	2,491	3,397	1,085	4,494	3,815	-157	-3,219	-1,495	-2,215	119
Investments	-22,856	-8,000	-56,194	20,695	901	881	-22,541	-17,211	-22,541	-22,541	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	6,860	3,466	63,241	5,971	4,856	2,969	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	-39,000	37,249	39,000	39,000	39,000	0	0	-1,133	0	0	-469	0	0	0	0	0	0	0
Net Income	30,105	20,636	26,907	21,220	17,934	22,943	17,177	10,590	7,758	3,915	3,202	2,571	2,143	6,013	1,598	-3,314	-2,934	-1,172	55	927
Other Cashflows From Financing Activities	7,131	-1,070	-401	60,449	-2,059	-1,199	-463	-385	-646	-520	31	23	50	49	108	328	-153	-4,522	-66	-774
Other Cashflows From Investing Activities	0	858	0	-70,604	-21,240	-4,882	-22,541	-14,370	-1,207	-6,574	-3,455	-3,989	199	0	0	0	0	399	710	0
Other Non Cash Items	2,283	4,720	3,531	1,628	1,249	-6,309	703	526	-65	931	643	1,122	1,021	1,503	769	1,777	493	160	33	488
Sale Purchase Of Stock	-853	-642	-802	-570	-683	-741	-778	-311	-266	-211	-373	-2,021	-2,213	-2,516	-686	-66	-82	-159	-561	-84
Stock Based Compensation	5,319	4,173	3,479	3,022	2,642	2,349	2,256	1,680	1,424	1,302	1,253	1,213	1,097	967	985	801	561	404	-539	0
Total Cash From Financing Activities	-7,131	-9,234	13,702	32,155	-4,622	-4,416	80	-2,577	1,079	6,662	-961	-3,157	-3,800	-2,335	-376	-24	10	31,171	2,488	1,358
Total Cash From Operating Activities	36,751	25,378	35,102	34,800	14,179	19,506	22,868	16,896	11,438	5,512	5,388	4,722	3,170	7,052	5,440	581	-1,826	-526	-1,202	1,682
Total Cashflows From Investing Activities	0	-10,371	-61,076	-52,891	-24,100	-7,055	-28,958	-17,211	-3,480	-7,748	-6,188	-5,198	-1,822	0	2,182	9,013	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31
Begin Period Cash Flow	18,051	19,488	16,677	19,134	16,913	20,788	15,560	13,855	17,369	21,541	23,525	26,764	29,279	19,976	10,944	11,786	11,719	13,264	14,766	26,318	20,104	19,638	22,781	19,096	37,514	30,120	25,810	24,288	34,650	29,315	25,941	27,451	23,629	19,430	17,025	18,692	18,354	23,512	12,504	14,711	13,626	14,910	15,302	16,448	20,639	20,162	19,622	20,132	23,087	21,405	19,103	22,614	27,453	25,608	23,662	23,192	19,809	16,740	14,093	15,895	13,163	10,648	5,444	6,691	7,752	12,474	13,241	15,391	453	666	469	817	0	0	0	0	0	0	0
Capital Expenditures	1,279	1,053	2,803	2,130	1,260	460	973	536	606	1,814	1,403	1,059	1,215	593	311	863	1,400	710	849	802	1,290	534	803	427	1,637	2,336	753	1,691	1,013	566	544	720	726	771	470	323	406	227	110	446	318	401	1,494	684	427	246	336	316	634	671	246	534	1,348	557	350	303	120	257	144	1,104	49	32	250	407	567	297	298	231	232	25	371	391	1,013	0	0	988	0	0	0
Cash And Cash Equivalents Changes	0	0	2,766	-2,510	1,553	-3,265	5,690	1,795	-3,349	-3,928	-2,044	-2,951	-3,180	8,985	9,101	-842	67	-1,545	-1,502	-11,552	6,214	466	-3,143	3,685	-18,418	7,394	4,310	1,522	-10,362	5,335	3,374	-1,510	3,822	4,199	2,405	-1,667	338	-5,158	11,008	-2,207	1,085	-1,284	-392	-1,146	-4,191	477	540	-510	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	-819	-2,531	-4,129	-3,252	-3,558	425	-3,919	-1,896	-889	-708	673	1,080	-3,071	-1,202	-1,964	-5,452	-1,942	-2,631	145	-3,545	-832	-448	1,323	-1,977	-788	32	1,784	-656	-561	827	-1,244	-239	-387	-165	956	-581	253	63	76	-469	262	-48	-10	-411	450	26	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	6,218	-1,437	2,811	-2,457	2,221	-3,875	5,228	1,705	-3,514	-4,172	-1,984	-3,239	-2,515	9,303	9,032	-842	67	-1,545	-1,502	-11,552	6,214	466	-3,143	3,685	-18,418	7,394	4,310	1,522	-10,362	5,335	3,374	-1,510	3,822	4,199	2,405	-1,667	338	-5,158	11,008	-2,207	1,085	-1,284	-392	-1,146	-4,191	477	540	-510	-2,955	1,682	2,302	-3,511	-4,839	1,845	1,946	470	3,383	3,069	2,647	-1,802	2,732	2,515	5,204	-1,247	-1,061	-4,722	-767	-2,150	14,938	-213	197	-348	0	0	0	0	0	0	0
Change In Working Capital	-2,688	10	-463	-8,113	-5,456	-2,344	-637	-4,965	-5,479	3,201	-3,136	-4,550	3,532	3,255	-1,083	-4,841	-2,098	-3,059	-2,618	-6,111	1,969	-1,704	43	-1,957	373	1,144	-797	-2,343	-156	1,653	1,083	-2,211	999	780	871	-3,339	-509	725	-1,436	-2,678	-928	543	-167	-2,238	-1,183	8	-23	-1,507	-2,835	849	1,582	-3,833	369	218	43	-1,057	-228	1,073	956	-1,356	1,047	405	926	-2,903	-1,158	1,458	-599	-1,680	353	-899	-600	-74	0	0	0	0	0	0	0
Change Receivables	0	0	-997	-3,242	-1,796	873	-659	-1,951	-393	1,061	-629	-857	387	-1,767	809	-368	-1,569	330	-92	30	-2,835	2,104	-1,123	571	-1,457	1,017	-209	-858	-854	708	49	-825	-801	771	-193	-1,656	-460	619	-881	68	-1,310	760	-251	-446	-539	337	-351	-87	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-1,058	2,162	-997	-3,242	-1,796	873	-659	-1,951	-393	1,061	-629	-857	387	-1,767	809	-368	-1,569	330	-92	30	-2,835	2,104	-1,123	571	-1,457	1,017	-209	-858	-854	708	49	-825	-801	771	-193	-1,656	-460	619	-881	68	-1,310	760	-251	-446	-539	337	-351	-87	248	-34	380	-768	-376	51	-134	-514	-75	100	-350	-161	27	48	78	8	197	0	0	-589	-689	0	0	0	0	0	0	0	0	0	0
Change To Inventory	-2,212	-3,310	-517	-3,755	-2,377	-1,505	-2,269	-1,267	-2,733	-708	-698	-1,346	619	848	-2,215	-1,861	-1,759	-4,288	-2,918	-2,370	-1,201	-1,755	-498	-808	-22	-563	335	-1,102	82	-480	656	-392	641	-384	746	-395	-223	-348	-1,143	-997	-225	-622	-702	-619	-647	-1,183	-1,158	-737	-1,062	-376	1,231	-791	-363	-525	-669	-178	-245	597	319	-507	978	791	180	-476	-472	-185	-162	-981	-2	-338	-228	-212	0	0	0	167	0	0	0
Change To Liabilities	0	0	1,353	-2,340	469	35	3,580	-3,439	-1,167	4,036	-1,618	-2,985	2,472	3,942	1,179	-3,271	1,435	2,063	-584	-3,510	4,659	-263	1,998	-2,080	737	1,337	-183	-367	-1,302	2,081	939	-1,821	2,403	632	705	-1,123	-782	944	564	-1,812	588	874	524	-1,125	-237	1,215	1,088	-709	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	0	1,942	2,001	1,618	1,902	3,926	1,265	1,476	1,445	2,097	2,071	1,053	660	1,291	1,318	1,638	1,000	982	1,095	-2,639	692	-4,984	819	794	1,008	654	573	820	622	482	422	-501	514	424	538	363	526	769	365	662	404	624	436	561	715	635	959	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	-302	-302	-1,752	-1,747	-1,289	1,692	-1,186	-1,188	-191	638	54	232	-856	659	-205	-1,164	976	-261	1,346	-1,790	-334	360	-288	-647	-740	-16	1,528	-656	-561	0	-2,035	0	0	0	553	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2,443	2,395	2,326	2,351	2,288	2,328	2,444	2,373	2,884	2,925	2,637	2,624	2,534	2,684	1,639	1,538	1,441	1,345	1,346	1,284	1,216	1,006	1,066	1,036	1,089	1,004	983	979	933	846	931	881	897	825	840	832	912	802	789	831	819	723	641	610	601	528	557	548	571	516	489	461	369	314	346	347	369	356	376	318	317	352	505	419	593	214	262	325	323	311	314	360	0	0	0	0	0	0	0
Dividends Paid	3,116	3,117	3,116	3,099	2,750	2,750	2,745	2,743	2,406	2,401	2,267	2,262	1,936	1,925	1,917	1,917	1,701	1,691	3,344	1,372	1,372	1,369	2,704	1,060	1,060	1,054	2,065	836	836	834	1,653	725	725	715	705	700	608	607	1,093	464	464	460	914	378	378	380	760	308	308	310	309	310	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	24,269	18,051	19,488	16,677	19,134	16,913	20,788	15,560	13,855	17,369	21,541	23,525	26,764	29,279	19,976	10,944	11,786	11,719	13,264	14,766	26,318	20,104	19,638	22,781	19,096	37,514	30,120	25,810	24,288	34,650	29,315	25,941	27,451	23,629	19,430	17,025	18,692	18,354	23,512	12,504	14,711	13,626	14,910	15,302	16,448	20,639	20,162	19,622	20,132	23,087	21,405	19,103	22,614	27,453	25,608	23,662	23,192	19,809	16,740	14,093	15,895	13,163	10,648	5,444	6,691	7,752	12,474	13,241	15,391	453	666	469	817	0	0	0	0	0	0
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-265	239	-303	76	-1	-311	-117	-583	198	56	234	350	178	-501	58	-21	193	-85	-28	60	-225	-166	-285	8	-2	-1	89	21	-85	-26	18	-61	18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	9,467	10,770	9,100	149	2,817	6,882	8,275	4,175	4,450	12,261	8,494	5,015	12,937	13,519	5,036	326	4,194	3,760	3,485	-1,021	5,281	3,774	4,073	3,324	5,133	5,862	4,671	785	3,181	5,784	4,550	538	3,199	3,440	3,432	-923	2,276	2,669	1,513	-2,135	1,038	1,990	493	-1,030	0	1,618	1,709	70	-937	1,704	2,956	-2,638	-379	2,066	2,291	516	1,849	2,906	2,470	-3,410	2,419	1,278	902	-4,756	-1,037	188	-271	-2,099	-264	-232	-1,265	266	0	0	0	694	0	0	0
Investments	-2,261	-9,851	-6,675	-564	-402	-8,000	-973	-536	-6,640	-49,553	1	-1	4,888	-15	14,925	897	12,279	1,797	-2,221	-10,954	3,829	7,809	-10,663	-94	-22,541	-22,541	-22,541	-22,541	-22,541	0	0	0	-22,541	0	0	0	-22,541	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	1,097	0	0	0	1,787	1,007	0	0	1,675	59,453	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	0	0	0	0	0	0	0	-23,000	-9,000	-7,000	-21,500	-4,500	63,249	65,000	65,000	65,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1,133	-1,133	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	8,465	7,502	8,098	6,040	5,627	5,456	3,515	6,038	6,175	6,504	8,299	5,929	7,033	7,513	3,500	3,174	4,613	5,184	4,624	3,513	6,025	4,314	8,751	3,853	4,284	5,042	4,632	3,219	2,597	3,229	2,598	2,166	2,530	2,092	1,767	1,369	1,916	934	1,272	-207	746	721	889	846	698	663	824	386	346	1,214	519	64	1,964	1,517	1,511	1,021	1,269	1,285	925	-1,881	312	-137	-925	-2,564	-1,178	-1,354	227	-629	-674	222	-1,090	370	41	5	51	47	112	334	434
Other Cashflows From Financing Activities	-2,261	-5	3,618	1,274	-1,308	-398	-363	363	39,000	-401	728	1,385	-1,824	-976	63,249	57	-2,000	-5,728	-3,393	-33	-28	-29	-3,816	-35	-36	-39	-2,193	-260	-136	-206	-43	-3,102	454	-1,100	-1,585	6	-393	-366	-1,093	28	31	-3,581	-914	-795	23	-150	-760	-312	50	632	-514	376	73	2	2	-28	4	104	-30	516	328	1,208	4,242	-262	-222	140	-6	-147	-5,393	56	571	244	3	0	0	0	0	0	0
Other Cashflows From Investing Activities	0	0	-161	-270	858	0	0	0	0	0	0	0	0	1,955	-72,500	-59	-14,425	-6,815	-13,175	-10,954	-1,282	-11,000	7,400	0	0	0	-753	-1,691	-10,172	-566	-1,250	-2,382	-150	196	-1,115	-138	-988	-5,386	6	-206	-23	-3,201	-112	-119	-4,110	54	108	-41	1,350	1,364	82	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	14	399	119	0	0	710	0	0	0	0	0	0
Other Non Cash Items	339	-97	23	711	1,116	716	2,790	98	511	-553	52	47	628	19	49	64	267	44	35	44	-1,042	-66	12	30	313	122	134	134	195	89	150	92	-453	35	143	210	115	-91	733	87	159	-8	346	159	-249	913	1,062	692	256	1,423	813	1,058	-1,989	218	445	223	279	106	59	325	-258	690	646	682	73	167	130	116	-432	109	482	1	0	0	0	0	0	0	0
Sale Purchase Of Stock	-667	-5	3,618	1,274	149	-3	-149	-145	-428	-286	728	-88	-279	-234	43	-57	-237	-423	528	-63	-63	-673	441	292	778	-778	1,482	-128	-128	-181	-2	141	266	-260	733	-6	211	-204	-6	-1	-39	-231	-13	-90	-36	-875	-508	-602	-754	-937	-146	-376	-1,202	-595	-399	-320	-506	-168	-10	-2	-29	-20	-9	-8	72	0	0	-85	-85	0	0	-74	0	0	0	0	0	0	0
Stock Based Compensation	1,404	1,313	1,312	1,290	684	1,186	1,136	1,167	886	797	869	927	753	687	803	779	547	655	694	746	555	537	636	621	411	886	472	487	485	533	332	330	336	479	281	328	320	439	265	278	286	412	278	277	277	406	267	263	250	317	267	263	264	262	226	215	266	274	227	218	801	0	0	173	561	0	309	116	404	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-2,686	-3,122	502	-1,825	-2,122	-2,147	-2,585	-2,380	-1,159	33,365	-10,539	-7,965	-21,005	-6,474	61,375	-1,741	-2,220	16	-2,842	424	-1,303	-1,303	-3,370	257	-1,066	1,298	-711	559	-1,042	-507	-1,169	141	847	585	28	-381	-790	-2,158	9,487	123	48	-183	-906	80	-61	-1,255	-1,239	-602	-1,476	-1,236	-418	-670	-1,102	-510	-375	-348	-344	-41	-10	19	-24	93	83	-176	-62	140	21	-89	30,353	-1	648	171	2,488	0	0	1,358	0	0	0
Total Cash From Operating Activities	10,746	11,823	11,903	2,279	4,077	7,342	9,248	4,711	5,056	14,075	9,897	6,074	14,152	14,112	5,347	1,189	5,594	4,470	4,334	-219	6,571	4,308	4,876	3,751	6,770	8,198	5,424	2,476	4,194	6,350	5,094	1,258	3,925	4,211	3,902	-600	2,682	2,896	1,623	-1,689	1,356	2,391	1,987	-346	427	1,864	2,045	386	-303	2,375	3,202	-2,104	969	2,623	2,641	819	1,969	3,163	2,614	-2,306	2,468	1,310	1,152	-4,349	-470	485	27	-1,868	-32	-257	-894	657	0	0	0	1,682	0	0	0
Total Cashflows From Investing Activities	0	0	-9,639	-2,964	-402	-8,460	-973	-536	-7,246	-51,368	-1,402	-1,060	3,673	1,347	-57,886	-25	-3,546	-5,728	-3,070	-11,756	1,257	-3,725	-4,066	-521	-24,178	-2,336	-753	-1,691	-13,013	-566	-530	-3,102	-865	-569	-1,585	-461	-1,388	-5,611	-110	-639	-318	-3,581	-1,494	-795	-4,531	-150	-205	-312	-1,822	-681	-1,313	0	0	0	0	64	2,182	388	486	516	9,013	8,685	7,477	3,235	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31
Cost Of Revenue	72,527	56,755	53,042	44,748	37,379	31,629	30,170	26,215	24,186	22,666	19,434	15,867	17,458	14,341	13,604	14,817	10,739	9,367	8,927	7,780	-	6,080	4,833
Depreciation And Amortization	9,515	9,433	11,070	8,395	5,416	4,324	4,055	3,591	3,394	3,334	2,793	2,234	2,037	1,376	1,419	1,593	1,394	1,308	1,208	967	-	-	-
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Ebit	37,082	21,164	25,552	19,801	15,767	8,937	21,103	16,336	7,399	4,516	4,518	1,510	5,210	6,347	4,042	-656	-1,729	-227	2,084	1,915	20,664	833	-282
Ebitda	46,597	30,597	36,622	28,196	21,183	13,261	25,158	19,927	10,793	7,850	7,311	3,744	7,247	7,723	5,461	937	-335	1,081	3,292	2,882	20,664	833	-282
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Extraordinary Items	0	0	0	0	0	400	400	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Gross Profit	120,957	104,896	101,382	84,618	79,853	73,939	70,697	62,936	54,166	48,431	45,115	40,868	40,227	41,719	37,304	33,903	30,707	25,261	21,800	18,403	20,664	11,284	7,717
Income Before Tax	39,475	27,490	34,287	27,356	21,679	28,444	21,106	16,242	11,424	6,320	4,328	3,993	3,752	4,025	2,215	-2,821	-2,702	-520	578	1,141	-	961	-602
Income Tax Expense	9,370	6,854	7,380	6,136	3,745	5,501	3,929	5,652	3,666	2,405	1,126	1,422	1,609	-1,988	617	493	232	652	523	214	222	478	3
Interest Expense	0	986	2,219	1,310	5,912	2	21	14	0	5	12	1	0	5	26	61	1	296	0	0	0	0	0
Interest Income	2,532	986	197	207	698	631	179	81	89	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Net Income	30,105	20,636	26,907	21,220	17,934	22,943	17,177	10,590	7,758	3,915	3,202	2,571	2,143	6,013	1,598	-3,314	-2,934	-1,172	55	927	-222	483	-605
Net Income Applicable To Common Shares	0	20,636	26,907	21,220	17,934	22,943	17,177	10,590	7,758	3,915	3,202	2,571	2,143	6,013	1,598	0	0	0	55	927	-	-	-
Net Income From Continuing Ops	27,267	20,636	26,907	21,220	17,934	22,943	17,177	10,590	7,758	3,915	3,202	2,571	2,143	0	0	0	0	0	0	0	-	-	-
Net Interest Income	2,532	986	-2,022	-1,310	698	629	158	67	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Non Operating Income Net Other	0	661	81	-122	496	237	24	-80	-89	-15	-178	-246	62	0	0	0	0	0	0	0	-	-	-
Non Recurring	0	3,107	0	-470	0	0	0	0	0	755	0	0	2,244	0	0	0	0	0	0	0	-	-	-
Operating Income	37,082	21,164	25,552	19,801	15,767	28,209	21,103	16,336	11,513	6,340	4,518	4,240	3,690	4,015	1,949	-2,930	-4,283	-679	422	1,157	20,664	833	-282
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Other Operating Expenses	156,402	131,715	117,999	101,048	96,049	84,833	79,764	72,815	67,199	64,002	60,031	52,743	52,486	49,744	47,076	49,906	44,314	35,050	29,307	24,591	-	16,531	12,832
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Reconciled Depreciation	9,360	9,433	11,070	8,395	5,416	4,324	4,055	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Research Development	16,966	13,294	11,801	10,099	9,276	8,197	6,636	6,141	5,479	4,671	5,243	5,092	4,425	5,488	5,910	5,328	4,591	3,301	3,015	2,120	-	1,295	862
Selling And Marketing Expenses	41,054	32,921	27,655	23,700	30,339	27,318	25,948	26,105	22,780	22,087	22,143	20,811	19,375	19,409	17,710	19,762	19,443	15,183	0	0	-	-	-
Selling General Administrative	31,832	28,745	25,501	22,501	19,055	17,689	17,010	14,354	14,010	13,889	12,576	10,973	11,228	10,506	9,852	9,999	28,977	7,105	20,180	16,611	-	-	-
Tax Provision	8,693	6,854	7,380	6,136	3,745	5,501	3,929	5,652	3,666	0	0	0	0	0	0	0	0	0	0	0	-	-	-
Total Operating Expenses	83,875	74,960	64,957	56,300	58,670	53,204	49,594	46,600	43,013	41,336	40,597	36,876	35,028	35,403	33,472	35,089	33,575	25,683	20,380	16,811	-	10,451	7,999
Total Other Income Expense Net	2,393	6,326	8,735	7,555	5,912	7,709	3	-94	271	-759	-182	-76	-1,458	-2,317	-1,629	-2,104	-1,139	-195	-664	-323	-	128	-320
Total Revenue	193,484	161,651	154,424	129,366	117,232	105,568	100,867	89,151	78,352	71,097	64,549	56,735	57,685	56,060	50,908	48,720	41,446	34,628	30,727	26,183	20,664	17,364	12,550

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31
Cost Of Revenue	17,106	16,596	18,029	16,192	14,900	13,958	14,298	13,599	13,547	13,502	13,909	12,084	13,146	13,712	7,822	10,068	10,262	8,934	9,168	9,015	9,171	6,910	8,028	7,520	7,901	7,245	8,237	6,786	7,094	6,197	7,022	5,902	6,080	5,509	6,767	5,830	5,853	5,498	5,785	5,530	5,960	4,584	4,714	4,176	4,363	3,630	3,816	4,058	3,888	4,381	4,742	4,447	4,084	3,258	3,502	3,497	3,411	3,603	3,508	3,082	3,686	3,920	3,853	3,358	2,961	2,563	2,702	2,513	2,162	2,279	2,665	2,261	2,421	2,288	2,157	2,061	2,023	1,906	1,984	1,867
Depreciation And Amortization	2,443	189	175	1,035	2,288	2,328	3,274	2,373	2,884	2,925	2,637	2,624	2,534	2,684	1,639	1,538	1,441	1,345	1,346	1,284	1,216	1,006	1,066	1,036	1,089	1,004	983	979	933	846	931	881	897	825	840	832	912	802	789	831	819	723	641	610	601	528	557	548	571	516	489	461	369	314	346	347	369	356	376	318	317	352	505	419	593	214	262	325	323	311	314	360	0	-	0	0	0	0	0	0
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	10,154	9,180	9,452	7,874	5,510	4,086	5,784	5,663	5,558	6,202	8,470	5,322	6,976	6,889	3,233	2,815	3,487	4,560	4,569	3,151	2,781	3,607	-1,277	3,826	5,233	4,049	4,553	3,214	2,976	4,498	2,852	2,419	2,192	1,776	1,954	1,477	2,015	1,066	1,691	-256	353	53	806	463	-171	466	947	1,052	946	1,654	1,703	1,059	946	2,040	2,085	897	1,243	1,308	1,043	284	-372	891	-141	-1,036	-613	346	-477	-983	-697	366	-375	479	0	0	0	0	0	0	0	0
Ebitda	12,597	9,369	9,627	8,909	7,798	6,414	9,058	8,036	8,442	9,127	11,107	7,946	9,510	9,573	4,872	4,353	4,928	5,905	5,915	4,435	3,997	4,613	-211	4,862	6,322	5,053	5,536	4,193	3,909	5,344	3,783	3,300	3,089	2,601	2,794	2,309	2,927	1,868	2,480	575	1,172	776	1,447	1,073	430	994	1,504	1,600	1,517	2,170	2,192	1,520	1,315	2,354	2,431	1,244	1,612	1,664	1,419	602	-55	1,243	364	-617	-20	560	-215	-658	-374	677	-61	839	-21,431	7,820	7,530	7,501	-18,046	6,546	6,546	6,546
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	31,777	30,815	32,086	30,883	26,054	25,070	27,810	25,962	25,956	24,866	26,761	23,799	24,402	22,704	17,029	20,483	19,908	20,166	20,315	19,464	19,218	17,255	18,992	18,474	18,252	17,577	17,516	17,353	16,194	17,019	15,367	14,356	14,403	13,516	13,130	13,117	12,828	12,003	12,376	11,224	11,956	10,716	11,237	11,206	10,438	10,015	10,545	9,870	9,523	10,183	10,370	10,151	10,347	10,398	10,656	10,318	10,173	9,743	9,122	8,266	8,425	8,103	8,886	8,489	8,143	7,581	7,613	7,370	6,595	6,261	6,095	6,310	7,876	7,820	7,530	7,501	6,545	6,546	6,546	6,546
Income Before Tax	11,313	9,826	10,319	8,017	7,798	6,148	5,548	7,996	7,905	8,434	10,455	7,493	8,931	9,378	4,767	4,280	5,188	5,890	6,088	4,513	7,251	4,730	11,547	4,916	6,328	5,073	5,466	4,239	3,834	5,307	3,836	3,265	3,135	3,139	2,824	2,326	2,693	1,899	2,000	-273	1,098	785	1,375	1,070	855	1,055	1,420	663	784	1,946	904	118	-1,302	2,065	1,963	1,299	1,312	1,463	1,114	-1,674	263	-59	-751	-2,274	-1,065	-961	-75	-601	-151	189	-1,019	461	578	0	0	0	1,141	0	0	0
Income Tax Expense	2,848	2,324	2,221	1,977	2,171	692	2,033	1,958	1,730	1,930	2,156	1,564	1,898	1,865	1,267	1,106	575	706	1,464	1,000	1,226	416	2,796	1,063	2,044	31	834	1,020	1,237	2,078	1,238	1,099	605	1,047	1,057	957	777	965	728	-66	352	4	486	224	157	392	596	277	438	732	385	54	-3,266	548	452	278	43	178	189	207	-49	77	175	290	113	393	-302	28	523	-33	71	91	-41	42	-5	-51	-231	-232	-232	-232
Interest Expense	0	0	0	143	447	264	167	108	526	621	495	577	579	665	66	105	0	0	0	0	2	2	2	2	21	0	0	0	14	0	0	0	14	0	0	1	1	6	0	6	6	6	8	3	1	0	0	2	2	2	0	2	2	3	3	4	6	4	2	22	296	15	16	16	182	359	344	5	137	176	54	46	182	0	0	0	137	0	0	0
Interest Income	992	835	682	568	447	264	167	108	141	54	1	1	13	15	74	105	124	193	224	157	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	8,465	7,502	8,098	6,040	5,627	5,456	3,515	6,038	6,175	6,504	8,299	5,929	7,033	7,513	3,500	3,174	4,613	5,184	4,624	3,513	6,025	4,314	8,751	3,853	4,284	5,042	4,632	3,219	2,597	3,229	2,598	2,166	2,530	2,092	1,767	1,369	1,916	934	1,272	-207	746	781	889	846	698	663	824	386	346	1,214	519	64	1,964	1,517	1,511	1,021	1,269	1,285	925	-1,881	312	-136	-926	-2,564	-1,178	-1,354	227	-629	-674	222	-1,090	370	41	-42	5	51	231	232	232	232
Net Income Applicable To Common Shares	0	0	8,098	6,040	5,627	5,456	3,515	6,038	6,175	6,504	8,299	5,929	7,033	7,513	3,500	3,174	4,613	5,184	4,624	3,513	6,025	4,314	8,751	3,853	4,284	5,042	4,632	3,219	2,597	3,229	2,598	2,166	2,530	2,092	1,767	1,369	1,916	934	1,272	-207	746	721	889	846	698	663	824	386	346	1,214	519	64	1,964	1,517	1,511	1,021	1,269	1,285	925	0	312	0	0	0	0	-227	227	0	-221	221	-370	370	41	-5	5	51	47	112	334	434
Net Income From Continuing Ops	8,465	7,502	8,098	6,040	5,627	5,456	3,515	6,038	6,175	6,504	8,299	5,929	7,033	7,513	3,500	3,174	4,613	5,184	4,624	3,513	6,025	4,314	8,751	3,853	4,284	5,042	4,632	3,219	2,597	3,229	2,598	2,166	2,530	2,092	1,767	1,369	1,916	934	1,272	-207	746	721	889	846	698	663	824	386	0	1,214	519	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	992	835	682	568	447	264	167	108	-385	-567	-494	-576	-579	-650	8	105	124	193	224	157	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Non Operating Income Net Other	0	0	867	143	831	-2	-236	68	130	-18	-156	125	-35	25	-39	-73	260	-15	173	78	60	117	6	54	28	20	-70	46	-61	-37	53	-35	46	-182	30	17	-46	53	20	-42	-80	15	-64	-49	-74	54	-35	-191	0	-45	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Non Recurring	0	0	180	305	0	0	3,107	0	0	0	0	0	0	-470	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	94	8	250	403	0	0	0	0	0	0	0	0	0	394	650	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	10,154	9,180	9,452	7,874	5,510	4,086	5,784	5,663	8,301	9,073	11,106	7,945	9,545	10,018	4,872	4,353	4,928	5,905	5,915	4,435	7,193	4,613	11,541	4,862	6,322	5,053	5,536	4,193	3,909	5,344	3,783	3,300	3,089	3,321	2,794	2,309	2,739	1,852	1,980	-231	1,172	776	1,447	1,123	930	1,001	1,455	854	832	1,991	897	-30	-1,295	2,032	2,008	1,270	1,229	1,293	993	-1,566	355	170	-869	-2,586	-1,317	-1,541	-447	-977	-433	343	-1,051	462	-21,431	7,820	7,530	7,501	-18,046	6,546	6,546	6,546
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	38,729	38,231	40,483	38,896	33,987	32,878	33,217	31,633	31,202	29,295	29,564	27,938	28,003	26,868	19,979	26,198	25,242	23,195	23,568	24,044	22,794	19,552	21,355	21,132	19,831	19,769	20,217	19,946	19,379	17,872	18,606	16,958	17,394	16,064	17,103	16,638	15,848	15,641	15,931	16,582	16,744	14,524	14,504	14,259	14,121	12,644	12,906	13,074	12,467	12,914	13,565	13,540	13,493	11,624	12,082	12,545	12,355	12,053	11,604	11,064	11,155	11,690	13,261	13,800	12,065	10,631	10,763	10,854	9,164	8,175	9,633	8,078	29,307	0	0	0	24,591	0	0	0
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Reconciled Depreciation	2,443	2,395	2,326	2,351	2,288	2,328	2,444	2,373	2,884	2,925	2,637	2,624	2,534	2,684	1,639	1,538	1,441	1,345	1,346	1,284	1,216	1,006	1,066	1,036	1,089	1,004	983	979	933	846	931	881	897	825	840	832	912	802	789	831	819	723	641	610	601	528	557	548	571	516	489	461	369	314	346	347	369	356	376	318	317	352	505	419	593	214	262	325	323	311	314	360	0	-	0	0	0	0	0	0
Research Development	4,351	4,224	4,516	3,875	3,554	3,462	3,346	2,932	3,457	2,848	2,652	2,844	2,869	2,098	2,139	2,994	2,499	2,281	2,256	2,240	2,347	2,037	1,988	1,825	1,583	1,761	1,634	1,658	1,521	1,539	1,634	1,446	1,575	1,421	1,331	1,152	1,081	1,109	1,137	1,344	1,402	1,300	1,268	1,273	1,561	1,261	1,135	1,135	1,139	974	1,040	1,272	1,475	1,135	1,338	1,540	1,716	1,448	1,435	1,311	1,301	1,203	1,474	1,350	1,175	1,144	1,118	1,154	715	805	986	795	3,015	0	0	0	2,120	0	0	0
Selling And Marketing Expenses	10,268	9,673	10,216	10,897	8,600	8,229	8,242	7,850	7,445	6,941	6,803	6,466	5,912	5,157	4,686	7,945	7,452	7,429	7,613	7,845	6,814	6,622	6,792	7,090	6,194	6,201	6,599	6,954	6,753	6,541	6,539	6,273	5,914	5,489	5,519	5,858	5,230	5,091	5,537	6,229	5,865	5,205	5,305	5,768	5,501	4,911	5,186	5,213	4,729	4,757	4,916	4,973	5,070	4,698	4,747	4,894	4,807	4,508	4,249	4,146	15,183	4,373	5,153	5,829	10,960	4,583	4,737	4,810	9,654	0	0	0	0	-	0	0	0	0	0	0
Selling General Administrative	8,440	7,738	7,722	7,932	6,933	7,229	7,331	7,252	6,753	6,004	6,200	6,544	6,076	5,901	5,332	5,191	5,029	4,551	4,531	4,944	4,462	3,983	4,547	4,697	4,153	4,562	3,747	4,548	4,011	3,595	3,411	3,337	3,635	3,455	3,303	3,617	3,513	3,765	3,296	3,315	3,345	3,282	3,067	2,882	2,696	2,892	2,769	2,668	2,711	2,802	2,867	2,848	2,864	2,533	2,495	2,614	2,421	2,494	2,412	2,525	6,682	6,537	7,886	8,657	7,929	6,924	6,943	7,180	5,037	5,866	6,592	5,817	20,380	0	0	0	16,811	0	0	0
Tax Provision	2,848	2,324	2,221	1,977	2,171	692	2,033	1,958	1,730	1,930	2,156	1,564	1,898	1,865	1,267	1,106	575	706	1,464	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0
Total Operating Expenses	21,623	21,635	22,454	22,704	19,087	18,920	18,919	18,034	17,655	15,793	15,655	15,854	14,857	13,156	12,157	16,130	14,980	14,261	14,400	15,029	13,623	12,642	13,327	13,612	11,930	12,524	11,980	13,160	12,285	11,675	11,584	11,056	11,314	10,555	10,336	10,808	9,995	10,143	10,146	11,052	10,784	9,940	9,790	10,083	9,758	9,014	9,090	9,016	8,579	8,533	8,823	9,093	9,409	8,366	8,580	9,048	8,944	8,450	8,096	7,982	7,469	7,770	9,408	10,442	9,104	8,068	8,061	8,341	7,002	5,896	6,968	5,817	-29,307	0	0	0	-24,591	0	0	0
Total Other Income Expense Net	1,159	-189	5	143	2,288	2,062	-236	2,333	-11	-72	-157	124	-35	495	-105	-73	260	-15	173	78	1,656	117	5,882	54	6	20	-70	46	-75	-37	53	-35	46	178	30	17	-94	44	-230	-445	-80	14	-66	-50	166	7	-49	-198	-164	292	-645	-941	-2,246	25	-122	26	75	159	73	-1,936	-246	-558	-381	-917	-348	-833	29	12	290	-1	-498	14	0	0	0	0	0	0	0	0
Total Revenue	48,883	47,411	50,115	47,075	40,954	39,028	42,108	39,561	39,503	38,368	40,670	35,883	37,548	36,416	24,851	30,551	30,170	29,100	29,483	28,479	28,389	24,165	27,020	25,994	26,153	24,822	25,753	24,139	23,288	23,216	22,389	20,258	20,483	19,025	19,897	18,947	18,681	17,501	18,161	16,754	17,916	15,300	15,951	15,382	14,801	13,645	14,361	13,928	13,411	14,564	15,112	14,598	14,431	13,656	14,158	13,815	13,584	13,346	12,630	11,348	12,111	12,023	12,739	11,847	11,104	10,144	10,315	9,883	8,757	8,540	8,760	8,571	7,876	7,820	7,530	7,501	6,545	6,546	6,546	6,546

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	193,484
Cost of Revenue	-72,527
Gross Profit	120,957	120,957

Operating Income (+$)
Gross Profit	120,957
Operating Expense	-83,875
Operating Income	37,082	37,082

Operating Expense (+$)
Research Development	16,966
Selling General Administrative	31,832
Selling And Marketing Expenses	41,054
Operating Expense	83,875	89,852

Net Interest Income (+$)
Interest Income	2,532
Interest Expense	-0
Other Finance Cost	-0
Net Interest Income	2,532

Pretax Income (+$)
Operating Income	37,082
Net Interest Income	2,532
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	39,475	34,689 EBIT - interestExpense = 37,082 39,475 30,105
Interest Expense	0
Earnings Before Interest and Taxes (EBIT)	37,082	39,475
Earnings Before Interest and Taxes (EBITDA)	46,597

After tax Income (+$)
Income Before Tax	39,475
Tax Provision	-8,693
Net Income From Continuing Ops	27,267	30,782
Net Income	30,105
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	156,402
Total Other Income/Expenses Net	2,393	-2,532

Technical Analysis of Lemaitre
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lemaitre. The general trend of Lemaitre is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lemaitre's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitions	Bullish trend (28.6%)		Bearish trend (-28.6%)
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of LeMaitre Vascular Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 67.26 < 68.14 < 70.89.

The bearish price targets are: 62.04 > 58.44 > 58.38.

Tweet this

LeMaitre Vascular Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of LeMaitre Vascular Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

MA 20 trending down: The MA 20 is trending down. -1
Close < MA 20: The price is below the MA 20. -1
MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
MA 50 trending up: The MA 50 is trending up. +1
Close < MA 50: The price is below the MA 50. -1
MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
MA 100 trending up: The MA 100 is trending up. +1
Close > MA 100: The price is above the MA 100. +1
MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
MA 200 trending down: The MA 200 is trending down. -1
Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving Average	Amount of candles	vs. MA 50	vs. MA 100	vs. MA 200
MA 20	20
MA 50	50	-
MA 100	100	-	-
MA 200	200	-	-	-

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

LeMaitre Vascular Inc Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of LeMaitre Vascular Inc. The current macd is -0.52436189.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lemaitre price going down in the near term. -2
MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lemaitre. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lemaitre price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1

LeMaitre Vascular Inc Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of LeMaitre Vascular Inc. The current adx is 14.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lemaitre shares, leading to potential downward momentum in its price. -1
PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.

LeMaitre Vascular Inc Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of LeMaitre Vascular Inc. The current sar is 62.49.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1

LeMaitre Vascular Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of LeMaitre Vascular Inc. The current rsi is 42.91. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Trending down: The RSI is trending down. -1

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

LeMaitre Vascular Inc Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of LeMaitre Vascular Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
STOCH < 20: The STOCH %K is below 20 and oversold. -2
STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lemaitre price going down in the near term. -2
Trending down: The STOCH %K is trending down. -1

LeMaitre Vascular Inc Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of LeMaitre Vascular Inc. The current cci is -95.46251164.

LeMaitre Vascular Inc Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of LeMaitre Vascular Inc. The current cmo is -20.05218.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1

LeMaitre Vascular Inc Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of LeMaitre Vascular Inc. The current willr is -87.6771411.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1

LeMaitre Vascular Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of LeMaitre Vascular Inc.

LeMaitre Vascular Inc Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of LeMaitre Vascular Inc. The current atr is 1.56490358.

LeMaitre Vascular Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of LeMaitre Vascular Inc. The current obv is 3,999,892.

LeMaitre Vascular Inc Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of LeMaitre Vascular Inc. The current mfi is 50.43.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

MFI > 50: +1

LeMaitre Vascular Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for LeMaitre Vascular Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-12-04	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2023-12-07	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-08	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2023-12-12	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2023-12-13	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-14	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-20	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-21	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2023-12-28	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
2023-12-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-03	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-01-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-01-09	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-10	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-16	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-01-18	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-01-22	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
2024-01-23	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-26	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-01-29	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-01-31	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-01	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-07	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-08	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-13	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-02-14	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-02-16	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-02-21	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-23	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-26	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-02-27	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-28	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-01	RSI	SHORT ENTRY	LONG CLOSE	70 crossover to downside
2024-03-07	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-11	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-12	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-20	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
2024-03-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-25	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-03-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-01	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-02	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-04-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-04-05	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-04-09	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-11	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-12	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-04-17	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-19	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-22	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-23	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-25	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside

6.3. Candlestick Patterns

LeMaitre Vascular Inc Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of LeMaitre Vascular Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Rsi	Greater than	50	42.907
Ma 20	Greater than	Ma 50	64.466
Ma 50	Greater than	Ma 100	65.171
Ma 100	Greater than	Ma 200	60.973
Open	Greater than	Close	63.500
Total			3/5 (60.0%)

Create your own Symbol Scanner

Get notifications about LeMaitre Vascular Inc

I send you an email if I find something interesting about LeMaitre Vascular Inc.

LeMaitre Vascular Inc Buy, Hold or Sell?

Let's analyse Lemaitre together

Get notifications about LeMaitre Vascular Inc

Quick analysis of Lemaitre (30 sec.)

What can you expect buying and holding a share of Lemaitre? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Lemaitre (5 min.)

$62.99

$13.26

$-1.13 - $16.83

$12.13 - $30.09

2. Growth of Lemaitre (5 min.)

Is Lemaitre growing?

How much money is Lemaitre making?

How much money comes from the company's main activities?

3. Financial Health of Lemaitre (5 min.)

4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)

Industry Rankings (Medical Instruments & Supplies)

What can you expect buying and holding a share of Lemaitre? (5 min.)

What can you expect buying and holding a share of Lemaitre?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Lemaitre

About LeMaitre Vascular Inc

Financial Health

Valuation

1.1. Profitability of LeMaitre Vascular Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.2. Return on Assets

Trends

Compared to industry (Medical Instruments & Supplies)

1.1.3. Return on Equity

Trends

Compared to industry (Medical Instruments & Supplies)

1.2. Operating Efficiency of LeMaitre Vascular Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

Compared to industry (Medical Instruments & Supplies)

1.2.2. Operating Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3. Liquidity of LeMaitre Vascular Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.3.2. Quick Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4. Solvency of LeMaitre Vascular Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

1.4.2. Debt to Equity Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

2. Market Valuation of LeMaitre Vascular Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

Compared to industry (Medical Instruments & Supplies)

LeMaitre Vascular Inc
Buy, Hold or Sell?